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Abstract 
Aging is a long-standing biological question of tremendous social and 
cultural importance. Despite this, only in the last 15 years has biology 
started to make significant progress in understanding the underlying 
mechanisms that regulate aging. This progress stemmed mainly from the 
use of model organisms, which allowed the discovery of several genes 
directly modulating longevity. Interestingly, several of these longevity genes 
are necessary for normal mitochondrial function, and disruption of their 
activity delays the aging process. This is somewhat paradoxical, 
considering the importance of cellular respiration for energy production and 
viability of eukaryotic organisms. One possible rationalization for this is that 
by decreasing cellular respiration, reactive oxygen species (ROS) 
generation is also reduced, and in that way, cellular decay and aging are 
delayed. The mechanism, however, may not be this simple, since it is 
unclear whether impairing mitochondrial respiration reduces ROS, and also, 
since not all long-lived mitochondrial mutants tested are resistant to ROS. 
Besides the long-life phenotype, these mitochondrial mutants also show a 
significant “slowing down” of rates of living (defecation, moving, eating and 
development to adulthood). Initial analysis of these phenotypes led to the 
suggestion that the increased longevity was not a regulated event, and 
instead was a consequence of a passive “slowing down” of the animals due 
to less energy availability. However, mitochondrial defects can only 
increase longevity if present during development, which in itself suggests 
the existence of a regulatory event. In order to understand the mechanisms 
by which mitochondrial impairment could be leading to increased longevity, 
we used the nematode C. elegans and performed gene expression analysis 
using microarrays, followed by functional analysis of candidate genes using 
RNAi. These studies suggested that mitochondrial mutations are affecting 
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longevity by up-regulating cellular defenses against toxic molecules and by 
activating alternative metabolic pathways. Interestingly, this is highly 
reminiscent of a transcriptional response observed in long-lived yeast with 
impaired mitochondria. This, in turn, strongly suggests evolutionary 
conservation of this pathway. When we looked for genes that were 
necessary for the increased longevity of mitochondrial mutants we identified 
the first regulator of this response, fstr-1/2. Importantly, fstr-1/2 is necessary 
for the “slowness” to occur in animals with defective mitochondria, which 
demonstrates that the response to mitochondrial dysfunction is actively 
regulated. This work also demonstrates that there are significant differences 
in how distinct mitochondrial mutants regulate their responses, although the 
overall nature of their responses is similar.  
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Sumário 
O envelhecimento é uma questão biológica antiga e de grande 
importância sócio-cultural. Apesar disto, os progressos mais significativos a 
nível mecanístico no campo da biologia do envelhecimento só se fizeram 
sentir nos últimos 15 anos. Estes progressos partiram, principalmente, da 
utilização de organismos modelo que permitiram a identificação de genes 
directamente envolvidos na regulação da longevidade. Muitos destes 
genes são necessários para o funcionamento normal das mitocôndrias e a 
inibição da sua função leva a um retardamento do processo de 
envelhecimento. Esta observação é algo inesperada, pois a respiração 
celular que se desenvolve nas mitocôndrias é extremamente importante 
para a produção energética e para a viabilidade das células eucarióticas. 
Uma razão possível para esta observação é que com a redução da 
respiração celular, também ocorre uma redução na produção de radicais 
livres (ROS) e, desse modo, a degeneração celular e o envelhecimento são 
adiados. No entanto, o mecanismo real deverá ser mais complexo pois, por 
um lado, a inibição da respiração celular nem sempre reduz os níveis de 
radicais livres, e por outro, nem todos os mutantes mitocondriais 
apresentam resistência a radicais livres. Para além do aumento no tempo 
de vida, estes mutantes mitocondriais também apresentam um 
“abrandamento” considerável na suas taxas de vida (defecação, 
movimento, alimentação, e desenvolvimento até adultos). Uma análise 
inicial destes fenótipos poderá sugerir que o aumento de vida observado 
nestes mutantes mitocondriais não é regulado biologicamente e é apenas 
uma consequência dum “abrandamento” passivo e generalizado dos 
animais devido a uma redução de produção energética. No entanto, esta 
explicação poderá ser demasiado simples, pois deficiências mitocondriais 
só afectam a longevidade se presentes durante o desenvolvimento pré-
 v 
embrionário, o que por si só, sugere a presença de um mecanismo 
regulador. Para compreender melhor os mecanismos responsáveis pelo 
aumento de longevidade em resposta a deficiências mitocondriais, nós 
focamo-nos no organismo modelo C. elegans. Analisamos os perfis de 
expressão génica destes mutantes usando “microarrays”, e seguidamente 
fizemos uma análise funcional dos genes com expressão alterada usando 
RNA interferência (RNAi). Estes estudos sugerem que as perturbações 
mitocondriais estão a afectar a longevidade através dum aumento da 
expressão de genes com funções protectoras contra moléculas tóxicas e, 
também, através da utilização de vias metabólicas alternativas. É 
importante notar que este fenómeno é muito semelhante à resposta 
transcricional observada em leveduras com deficiências mitocondriais que 
também têm vida prolongada. Esta observação é um forte indício de que 
este mecanismo de regulação de longevidade em resposta a deficiências 
mitocondriais é evolutivamente conservado. Quando procurámos genes 
necessários para o aumento do tempo de vida observado em mutantes 
mitocondriais, encontrámos o fstr-1/2, o primeiro regulador deste 
mecanismo descrito até agora. É de notar que a actividade deste gene é 
necessária para o “abrandamento” observado nestes animais, o que por si 
só, demonstra que esta resposta à inibição mitocondrial é regulada e não 
apenas uma consequência passiva de falta de energia. Este trabalho 
também evidencia diferenças ao nível da regulação da resposta 
transcricional entre os diferentes tipos de mutantes mitocondriais em C. 
elegans. No entanto, apesar dos mecanismos de regulação serem 
diferentes, as respostas transcricionais dos diferentes mutantes são 
semelhantes. Isto sugere que estes mutantes mitocondriais activam 
respostas semelhantes que regulam a longevidade através de mecanismos 
diferentes. 
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Chapter I  
Introduction  
“To get back my youth I would do anything in the world, except take 
exercise, get up early, or be respectable.” – Oscar Wilde 
 
Aging is a widespread process with deep-rooted implications in our lives 
and societies. Humanity has struggled to understand this mystery and its 
implications for millennia, and even presently, many questions remain. It 
has captured the imagination of many philosophers and artists. Great 
literary works were created either embracing the inevitability of aging or 
fantasizing about eternal youth. The idea of prolonged life is a common 
mythological theme in many cultures, and an intrinsic part of our collective 
imagination. More so, the search for long life is not a recent trend, in fact, 
Juan Ponce de Leon, an influential Spanish explorer, in 1513 found himself 
dissatisfied with his riches and set out on a quest for the fountain of youth, 
discovering Florida in the process (Oviedo 1535; Gómara 1551). Already 
many years before this “conquistador’s” adventure, in the 1300s, alchemy 
attempted to, besides the noble goal of turning household items into gold, 
create a liquid “panacea” that would heal all illnesses and allow eternal life 
(Burland 1989). 
However, besides the more philosophical, historical and imaginative 
aspects of aging, there are present day socio-economical implications that 
need to be understood and acted upon. Many countries in the developed 
world, mainly Western Europe and Asia, due to improved medical and 
sanitary conditions and decreased birth rates, have increasingly aged 
populations. This inflates the social burden due to higher health care costs 
(Saltman, Dubois et al. 2006). In addition, there is a significant decrease in 
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economic growth since the main consumer base consists of younger people 
(Krulwich 2006). Also, as the fraction of elderly individuals increases, it is 
important to understand the underlying physiological changes of aging and 
age-related disease, developing appropriate medical procedures in the 
process. 
 More relevantly to this work, the aging process represents a major 
unanswered biological question of tremendous scientific interest and 
potential. A complex task that requires an interdisciplinary approach, its 
study generates a better understanding of both fundamental biological 
processes and age-related disease. It is a compelling question that fuels 
the imagination of scientists and non-scientists alike. 
 
1.1 - Aging in Biology – “What is aging?” 
There is no simple definition since there are several phenotypes 
associated with aging, some of which are shared between a wide range of 
species, some of which are unique. However, aging can be defined broadly 
as the age-associated decline of physiological and neurological processes 
leading to a decrease in overall function of an organism. 
It is important to note that bacteria and certain mammalian cells in 
culture have the ability to divide almost indefinitely, so, clearly, the potential 
to keep cellular stability through time exists. Yet, despite of this, most 
organisms lose function, age and eventually die. So the question remains, 
why do organisms age? 
 
1.2 - Theories of Aging – “Why do we age?” 
Evolutionary biologists have considered the aging problem extensively 
and have developed several compelling theories. Weissman initially 
proposed (Weismann, 1891) that aging is a genetically programmed means 
of controlling population size and avoiding overcrowding and depletion of 
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resources. Along these lines, a commonly heard argument for aging as an 
evolutionarily selected process is that it increases generation turnover, thus 
facilitating adaptation to changing environments. This theory is no longer 
believed to be accurate, mostly due to three evolutionary arguments: Firstly, 
in the wild, animals tend to die early from extrinsic causes (predation, 
climate, disease), thus making the effects of aging as a population control 
mechanism negligible (Medawar, 1952). Secondly, since the majority of the 
animals die young, natural selection cannot act on phenotypes that occur 
later in life. Thirdly, because senescence is mainly post-reproductive, 
mutations that affect this life period are less likely to be selected for, since 
they should have minimal effects on fitness. Hence, it is hard to imagine 
how a mechanism with no function other than to regulate longevity may 
have been selected for. This does not mean, however, that genes cannot 
affect longevity, but that aging per se was not evolutionarily selected for.  
Along these lines, we have a more widely accepted theory of aging, the 
mutation accumulation theory of aging. This theory states that because 
natural selection cannot act later in life, populations will tend to randomly 
accumulate mutations that will have deleterious effects in older organisms. 
The mutations that act the latest are exposed to lower selective pressures, 
which allows an accumulation of progressively worse phenotypes as 
animals age (Kirkwood 2002). This theory predicts that over the span of 
many generations there will be a severe decrease in overall function in 
older organisms, in other words, aging. 
An interesting follow-up to the mutation accumulation theory is the 
antagonistic pleiotropy theory of aging, which states that mutations that 
increase fitness early in life will be selected for, even when they have 
detrimental effects later in the life of the organism (Williams, 1957). Some 
authors go as far as to defend that all mutations with detrimental effects 
later in life are selected for their beneficial effects early in life. Some have 
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argued that a consequence of this reasoning is that any mutation extending 
longevity should decrease fitness of younger animals. 
This has prompted the disposable soma theory of aging, stating that 
animals have limited resources to tap over the course of their lives. These 
resources are optimized for maintenance of the germline in liu of longevity, 
hence any condition that delays aging should negatively affect fertility 
(Kirkwood and Holliday 1979). In a simplified way, why spend valuable 
resources on protective enzymes that will allow the animal to live to 30 
years when those resources would be better spent on reproduction, which 
ends at 15 years of age? This theory predicts that, any process that 
increases longevity leads to decreased fertility (Kirkwood and Holliday 
1979). However, experimentally, this “trade-off” is not always present, thus 
suggesting that this theory is incomplete. Either the organism’s resources 
are not limited or there is room for further optimization of their allocation that 
would allow increases in longevity without a reproductive “trade-off”. 
Currently, most evolutionary biologists tend to defend a mixed model 
involving the “mutation accumulation” and “antagonistic pleiotropy” theories. 
It is interesting to note that, although aging is a widespread phenomenon 
with shared characteristics throughout different species, evolutionary 
biologists predict it not to be genetically regulated (Kirkwood 2002). 
However, work done in the last 15 years has uncovered numerous lifespan-
increasing mutations and has started to suggest that this view may be an 
oversimplification. 
Another popular theory of aging is the rate of living theory. A century 
ago, Max Rubner noted that animals with higher metabolic rates often had 
shorter lifespans; this observation led to the rate-of-living theory of aging 
(Kirkwood 2002). In a very simplistic way, this is the “live fast, die young” 
theory of aging. The author proposed that all organisms possessed a 
certain amount of a “vital substance” that when used up would lead to 
death. For many years, the mechanistic connection between metabolic rate 
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and lifespan remained elusive. With the discovery of cellular oxidants (see 
section 1.3.1) however, this theory gained momentum as these provided 
the perfect connection between metabolic rate and longevity. Increased 
metabolic rates led to more oxidant-related damage which, in turn, 
decreased longevity. Although it is an attractive hypothesis due to its simple 
and intuitive nature, presently most scientists regard it as incomplete, 
mostly because the correlation between metabolic rate and lifespan is 
inconsistent across species. This is particularly true for birds and primates, 
which tend to live longer than predicted by their metabolic rates (Finkel and 
Holbrook 2000). Analysis of free radical formation in these species led to 
the finding that they have decreased production of toxic oxidants, 
suggesting that this could be the cause of their increased longevity. For a 
complete answer to our questions, theoretical models of aging need to be 
accompanied by experimental data. This experimental approach allows us 
to address another outstanding question in the field of aging research: How 
do we age? What are the causes of aging? 
 
1.3 - Cellular Causes of Aging – “How do we age?” 
Until now, we have discussed a non-specific decrease in function of 
living organisms, but on a more mechanistic note, exactly what causes the 
decrease in function observed with aging? If it is non-specific damage, why 
does it consistently affect a subset of processes? 
 
1.3.1 - Oxidants and Aging 
Presently, the most widely accepted culprits for age-associated decline 
in cellular and organismal function are reactive oxygen species (ROS), 
according to the free radical theory of aging (Harman 1956).  
ROS, also called free radicals or oxygen radicals are highly reactive 
small molecules containing unpaired electrons. These molecules can react 
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with several organic molecules (nucleotides, proteins or lipids) and, in doing 
so, can cause considerable damage, impairing normal cellular function 
(Finkel and Holbrook 2000; Kirkinezos and Moraes 2001).  
In the mid 1950s Denham Harnham introduced his free-radical theory of 
aging by speculating that cells generated endogenous oxygen radicals, 
which, in turn, resulted in a pattern of age-related cumulative damage.  
Although, at first, the concept of endogenous oxidants was highly 
controversial, it gained momentum with the discovery of the first superoxide 
dismutase (SOD) enzyme (McCord and Fridovich 1969). Superoxide 
dismutases belong to a large family of important enzymes that detoxify 
ROS. SODs, in particular, are responsible for converting the superoxide 
anion (.O2-) into the more stable hydrogen peroxide (H2O2). H2O2, in turn, 
can be broken down into innocuous water (H2O) and oxygen (O2) by the 
enzymes catalase (Loew 1900) and glutathione peroxidase (Finkel and 
Holbrook 2000). However, if left unchecked, both superoxide and hydrogen 
peroxide molecules can lead to the production of the highly reactive 
hydroxyl radical (O2- ), which is thought to be responsible for most cellular 
oxidative damage (Beckman and Ames 1998). Besides the aforementioned 
detoxifying enzymes, several other non-enzymatic, low molecular mass 
molecules can be found in cells that share their role in scavenging ROS. 
These include ascorbate, pyruvate, flavonoids, carotenoids and perhaps 
most importantly, glutathione (Finkel and Holbrook 2000).  
 ROS can damage three kinds of organic molecules: lipids, proteins and 
nucleotides. When reactive oxygen species react with cellular lipids, there 
can be significant decrease of membrane fluidity and generation of 
endoperoxides and unsaturated aldehydes. The latter are highly reactive 
and may act as mutagens, inactivate enzymes or operate as endogenous 
cross-linking agents (Beckman and Ames 1998). When ROS damage 
nucleotides, there may be formation of adducts of base and sugar groups, 
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single- and double-strand breaks in the nucleotide backbone, or cross-
linking to other molecules. These altered nucleotides can eventually lead to 
mutation, DNA rearrangements or problems during transcription (Beckman 
and Ames 1998). Oxidation of proteins by oxygen radicals leads to 
formation of carbonyls, protein-protein cross-linking, peptide fragmentation 
and inactivation of proteins with iron-sulfur clusters (Beckman and Ames 
1998). Overall, any of these interactions between ROS and biomolecules 
promote cellular dysfunction. 
More importantly, however, there are several compelling lines of 
experimental evidence for the involvement of ROS in the aging process. 
Starting with the observation that, as animals age there is an accumulation 
of oxidant-damaged molecules in cells such as: protein carbonyls (Nystrom 
2005), cross-linked lipid and protein species (lipofuscin) (Beckman and 
Ames 1998) and oxidant-damaged nucleotides, particularly mitochondrial 
DNA (mtDNA) (Esposito, Melov et al. 1999; Melov, Coskun et al. 1999). In 
addition, several age-related neurodegenerative diseases such as 
Parkinson’s disease (Seaton, Cooper et al. 1997) or Alzheimer’s disease 
(Mecocci, MacGarvey et al. 1994) show increased oxidative damage and 
mutations that increase steady-state ROS levels can lead to an early form 
of this diseases (Tu, Raju et al. 1996). Werner’s syndrome, which is widely 
regarded to be a progeric (accelerated aging) process also leads to 
increases in protein carbonylation (Oliver, Ahn et al. 1987). It is also 
noteworthy that increasing atmospheric O2 concentration in C. elegans, 
which increases oxidative stress, has been demonstrated to decrease 
longevity (Honda and Matsuo 1992). Moreover, It has been demonstrated in 
mice that the heterozygous state of sod-2(+/-) gene is enough to accelerate 
aging (Kokoszka, Coskun et al. 2001). However, this conclusion has been 
put into question by another study demonstrating that this decrease in sod-
2 levels, although increasing mitochondrial oxidative damage, does not 
affect longevity (Van Remmen, Ikeno et al. 2003). Overexpression of 
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superoxide dismutase leads to an increased lifespan in yeast (Harris, 
Bachler et al. 2005) and overexpression of SOD and catalase increase 
longevity of D. melanogaster (Orr and Sohal 1994; Sun and Tower 1999). 
Interestingly, flies can benefit from an increase in longevity when SOD is 
overexpressed only in the neurons arguing that this could be a rate-limiting 
tissue (Parkes, Elia et al. 1998), or there could be non-autonomous 
regulation originating in the neurons. Also, exposure to superoxide/catalase 
mimetics can extend C. elegans longevity up to 44% (Melov, Ravenscroft et 
al. 2000), although that work has been recently been put into question 
(Keaney, Matthijssens et al. 2004), interestingly, the latter authors saw a 
decrease in oxidative damage, but observed no effects on lifespan. Many 
long-lived C. elegans mutants show increased stress resistance which 
correlates with increased expression of sod-3, the nematode’s SOD (Honda 
and Honda 1999; Feng, Bussiere et al. 2001; Henderson, Bonafe et al. 
2006). In addition, certain short-lived C. elegans mitochondrial mutants, 
which show hallmarks of accelerated aging, have increased ROS-related 
damage (Ishii, Fujii et al. 1998; Kayser, Sedensky et al. 2004). However, 
the correlation between accelerated aging and increased ROS has been 
broken in several instances, which leads us to an important question: 
Is oxidative stress resistance an absolute requirement for longevity? Is 
it, moreover, the sought-after mechanism of lifespan regulation? 
Experimental evidence suggests that the answer to these questions may 
not be a simple one. For instance, chico mutants in Drosophila are long-
lived, but exhibit normal levels of resistance to oxidative stress (Clancy, 
Gems et al. 2001). In addition, mice knockout mutants for SOD1, SOD2, 
SOD3 or GPX1 (glutathione peroxidase) genes do not display a phenotype 
of accelerated aging (Reaume, Elliott et al. 1996; Melov, Schneider et al. 
1998), despite increased levels or ROS. Finally, in C. elegans, expression 
of non-stress response genes is also influenced by insulin/IGF-1 signaling 
and some of them have been shown to contribute to the longevity of long-
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lived mutants (Murphy et al. 2003, Lee, Kennedy et al. 2003). Thus, further 
research is required to determine the exact relationship between oxidative 
stress resistance and the regulation of longevity. 
It is well established that during oxidative stress, accumulation of ROS 
leads to cellular damage. However, under physiological circumstances ROS 
have several “legitimate” cellular functions: they act as essential signaling 
molecules involved in wound healing (Sen 2003), recruitment of leukocytes 
during the adaptive immune response (Guzik, Korbut et al. 2003), 
regulation of aconitase activity (Gardner and Fridovich 1991; Gardner, 
Raineri et al. 1995; Irani, Xia et al. 1997) and regulation of the Ras pathway 
(Irani, Xia et al. 1997; Shibata, Branicky et al. 2003), mostly in the form of 
nitric oxide (NO·) and superoxide (.O2-). These newly-found roles of ROS in 
cellular signaling may have significant implications for their relationship to 
the aging process. Since the data suggests that there is an increase in free 
radicals in older organisms, it is tempting to speculate that many ROS-
signaling dependent cellular processes will be altered with age, leading to a 
decrease in overall function of the organisms (Beckman and Ames 1998). 
This is an attractive hypothesis because potentially, smaller, more 
physiological amounts of “illegitimate” ROS could cause significant cellular 
miss-regulation and lead to aging. 
 
1.3.2 - Mitochondria and Aging  
As mentioned above, cells possess several enzymatic systems that 
allow them to produce “legitimate” ROS in a controlled fashion, to be used 
as regulatory molecules. Despite this fact, the majority of ROS is toxic and 
is generated as a by-product of the activity of one cellular organelle, the 
mitochondrion. Importantly, due to the proximity to the source, the primary 
targets of oxidant-related damage are also thought to be the mitochondria 
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themselves. In this way, mitochondria may be predicted to have a role in 
aging as the cell’s main sources of ROS. 
Mitochondria are complex cellular organelles consisting of two lipid 
membranes (outer and inner) with unique properties that separate two 
distinct compartments: the intermembrane space and the matrix (space 
inside the inner membrane) (Fig. 1).  
 
 
 
Figure 1 – Mitochondrial structure. Mitochondria have two distinct membranes 
(inner membrane and outer membrane) which separate two distinct compartments: 
matrix and inter membrane space. Mitochondria have their own genetic material, 
the nucleoid, which is circular and encodes their own set of translational machinery 
(ribosomes). These ribosomes are similar to bacterial ribosomes and distinct from 
eukaryotic ribosomes. This image was adapted from a wikicommons image. 
 
According to the endosymbiotic theory (Wallin, 1923; Stocking 1959), 
mitochondria are thought to have arisen 1.7 (Feng, Cho et al. 1997; 
Emelyanov 2001) to 2 billion years ago (Feng, Cho et al. 1997; Emelyanov 
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2001) from an endosymbiotic proteobacteria that survived an endocytosis 
event. This pre-mitochondrial bacterium or proto-mitochondrion provided an 
evolutionary advantage to the host cell by performing aerobic respiration in 
cells that would have otherwise relied on less-efficient pathways of 
glycolysis and fermentation for energy (Sagan 1993). Although the majority 
of mitochondrial proteins are encoded in the nucleus, mitochondria contain 
their own genetic material (mtDNA) and translational machinery, 
reminiscent in many aspects of their prokaryotic evolutionary origins 
(Emelyanov 2003; O'Brien 2003). It is thought that over the millions of years 
since the appearance of eukaryotic organisms, much of the mitochondrial 
genetic material was transferred to the nucleus (Alberts et al., 2002). 
mtDNA molecules are usually circular, small (≈ 16 kb), attached to the inner 
mitochondrial membrane and code for ≈37 mitochondrial proteins essential 
for aerobic respiration (this number varies between species) (Alberts et al., 
2002). This means that, although most mitochondrial proteins are encoded 
in nuclear DNA, cells with deficiencies in mtDNA are unable to perform 
mitochondrial respiration (see yeast “petites”, section 1.4.3). 
 Mitochondria serve several functions in eukaryotes: through unique 
metabolic reactions, they are the cell’s main source of energy, in the form of 
adenosine-triphosphate (ATP); they are essential in sequestering potentially 
toxic Ca2+ ions (Chan 2006); they serve an important role in apoptosis 
(Hengartner 2000); and they are necessary for steroid and heme synthesis 
(Chan 2006). Nevertheless, the most intensively studied and arguably the 
most important of mitochondrial functions is energy generation. 
In the presence of oxygen, most cellular ATP is produced through 
aerobic respiration. This occurs in four distinct steps: the first one, 
glycolysis, which is not considered aerobic respiration per se, takes place in 
the cytosol. The next three steps occur in the mitochondria: pyruvate 
decarboxylation, the Krebs cycle and oxidative phosphorylation (Fig.2).  
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Figure 2 – Overview of aerobic respiration. ETC – electron transport chain; OAA 
– oxaloacetate; α-KG – α-ketoglutarate; Pyr. Decarb. – pyruvate decarboxilation. 
NADH produced during glycolysis may also be used by the ETC to produce ATP, 
however its transport into the mitochondria requires energy expenditure. 
 
Glycolysis converts one molecule of glucose into two molecules of 
pyruvate, two molecules of ATP and two molecules of the reducing 
equivalent nicotinamide adenine dinucleotide (NADH). The resulting 
pyruvate is imported by the mitochondria where it is oxidized and combined 
with coenzyme A to produce two molecules of NADH and acetyl-CoA, 
which is the primary substrate of the tricarboxylic acid cycle (TCA) or Krebs 
cycle (Berg et al., 2002). In the mitochondrial matrix, the Krebs cycle 
converts acetyl-CoA to carbon dioxide (CO2) and in this process there is 
production of: reducing equivalents, comprising three molecules of NADH 
and one molecule of flavin adenine dinucleotide (FADH); and, energy, in the 
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form of one GTP molecule that can be readily converted to ATP. The Krebs 
cycle is not only a central process in energy generation, but also produces 
many biochemical intermediates essential to other metabolic pathways 
such as glutamate, a key intermediate in amino acid metabolism that is 
generated from α-ketoglutarate (Butow and Avadhani 2004). Besides 
pyruvate decarboxylation, which yields acetyl-CoA, several other catabolic 
pathways provide intermediates for the Krebs cycle, especially when these 
intermediates are scarce. These are called anaplerotic pathways (Butow 
and Avadhani 2004). There are several different anaplerotic pathways, 
which can “feed” into different steps of the Krebs cycle (see chapter 3.4.1). 
The last step in aerobic respiration, called oxidative phosphorylation, 
occurs in the inner mitochondrial membrane and converts reducing 
equivalents and oxygen into energy and water. These reducing equivalents, 
NADH and FADH, result mainly from the Krebs cycle. They are so named 
because they can donate electrons to other molecules, reducing them, and 
in the process donating redox energy contained in their molecular bonds. 
During oxidative phosphorylation, reducing equivalents donate electrons to 
the final acceptor O2 in several steps via the electron transport chain (ETC) 
(Fig.3).  
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Figure 3 – Electron transport chain (ETC). Thin interconnected arrows depict 
flow of electrons. Q - electron carrier ubiquinone. Cyt c – electron carrier 
cytochrome c. H+ - proton. Pi – phosphate. This image is adapted from a 
wikicommons image. 
 
 The electron transport chain comprises ubiquinone and cytochrome 
electron carriers and four protein complexes (complex I-IV) embedded in 
the inner mitochondrial membrane. These complexes transfer electrons 
sequentially to one another and to the final acceptor, molecular oxygen 
(O2), producing water (H20). In this process the redox energy generated 
during the electron flow is used by complex I, II and IV to pump protons 
(H+) into the intermembrane space, creating an electrochemical gradient 
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which is used by the highly conserved ATP synthase (sometimes called 
complex V) to generate ATP.  
During oxidative phosphorylation, each O2 molecule must accept two 
electrons to become fully reduced to H2O, however, the process is 
imperfect and often only one electron is donated, leading to the formation of 
the above mentioned superoxide anions. The frequency of such events had 
been reported to be as high as 1-2% of all oxygen molecules (Boveris and 
Chance 1973), however presently it is believed that the frequency is 10-fold 
lower, at 0.1% (Imlay and Fridovich 1991). Nevertheless, 0.1% ROS 
generating events is still enough to qualify the mitochondria as the main 
source of cellular ROS. The formation of superoxides happens mostly at 
two discrete steps, complex I (NADH dehydrogenase) and Complex III 
(ubiquinone-cytochrome c reductase). Under normal conditions complex III 
is the main site of ROS formation (Turrens 1997). Studies have shown that 
the rate of flow of electrons during oxidative phosphorylation can influence 
the amount of ROS produced and many treatments that affect electron flow 
(complex activity inhibitors) produce increases in ROS production (Lenaz 
2001). It is accepted that there is an optimal rate of electron flow in the ETC 
during oxidative phosphorylation, and both increases and decreases in this 
rate can lead to increased ROS production. Consistent with the idea that 
the mitochondria are a major source/target of oxidative stress, 
mitochondrially-dedicated superoxide dismutases and catalases have been 
identified (Fridovich 1995) and a component of the ETC, cytochrome c, acts 
as a powerful antioxidant (Beckman and Ames 1998). It is particularly 
interesting to note that several enzymes containing an active-site iron-sulfur 
cluster are deactivated in the presence of superoxide anions (Kuo, Mashino 
et al. 1987; Flint, Tuminello et al. 1993). Aconitase, which is an integral part 
of the Krebs cycle, has been experimentally shown to be inactivated in the 
presence of superoxide anions (Gardner and Fridovich 1991; Gardner, 
Raineri et al. 1995). Since the Krebs cycle is such a key metabolic process, 
 15 
we can predict that the increase in ROS seen with age can also lead to 
increased metabolic dysregulation, with grave and pleiotropic cellular 
consequences. 
According to the free radical theory of aging, oxidant-related damage is 
an important player in the aging process, and since mitochondria are the 
cells’ main ROS generators, they too are likely to have an important role in 
aging. Furthermore, it follows that, since the mitochondria are the main 
source of ROS they are also extremely susceptible to oxidative damage, by 
proximity. Experimental evidence supports this, as there is decreased 
mitochondrial function with age, in the form of damaged mtDNA (Melov, 
Lithgow et al. 1995). The mitochondrial genome contains 13 subunits of 
complexes I, III and IV. Mutations in these genes lead to decreased 
mitochondrial function and increased ROS generation (Beckman and Ames 
1998). This is thought to create a positive feedback loop or “vicious cycle” 
where oxidant-damaged mitochondria produce more oxygen radicals, which 
in turn exacerbate their own damage (Finkel and Holbrook 2000; Kirkinezos 
and Moraes 2001). Consistent with this theory, large deletions of the 
mitochondrial genome (∆mtDNA) accumulate exponentially in aging 
humans (Cortopassi and Arnheim 1990), C. elegans (Melov, Lithgow et al. 
1995), mice (Chung, Weindruch et al. 1994; Tanhauser and Laipis 1995), 
rats (Edris, Burgett et al. 1994) and rhesus monkeys (Lee, Chung et al. 
1993). In addition, increased frequencies of ∆mtDNA are found in age-
associated neurodegenerative diseases such as Huntington’s and 
Alzheimer’s disease. (Beckman and Ames 1998). Moreover, point 
mutations accumulate in mtDNA with age (Michikawa, Mazzucchelli et al. 
1999; Wang, Michikawa et al. 2001). It has been demonstrated that 
oxidative damage is more extensive and persists for longer in mtDNA than 
in nuclear DNA (Yakes and Van Houten 1997), potentially due to less 
efficient DNA protection mechanisms in the mitochondria. Nevertheless, the 
“mtDNA mutation accumulation” theory of aging, as it is known, remains to 
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be proven conclusively. It is still unclear whether the increase in frequency 
of ∆mtDNA and mtDNA point mutations is causally related to increased 
oxidative damage, or is merely a biomarker of aging.  
Further emphasizing the connection between mitochondria and aging, 
work done in C. elegans and S. cerevisiae has uncovered several mutants 
with impaired mitochondrial function that have altered lifespans. Some of 
these mutants have shortened lifespans (Ishii, Fujii et al. 1998; Kayser, 
Sedensky et al. 2004), whereas others, interestingly, live considerably 
longer than their wild-type counterparts (Wong, Boutis et al. 1995; 
Kirchman, Kim et al. 1999; Epstein, Waddle et al. 2001; Feng, Bussiere et 
al. 2001; Traven, Wong et al. 2001; Dillin, Hsu et al. 2002; Lee, Lee et al. 
2003). These fascinating long-lived mitochondrial mutants and the 
regulation of their phenotypes will be the focus of this PhD thesis (for a 
more detailed discussion of these mutants, please see section 1.4.3).  
 
1.3.3 - Other potential causes of aging 
This section presents an overview of other cellular processes potentially 
involved in aging that are beyond the scope of this thesis.  
The discovery of telomeres (reviewed in Blackburn 1990), telomerase 
(Blackburn, Greider et al. 1989) and their role in cellular senescence 
pointed to an obvious connection between telomeres and aging (Kruk, 
Rampino et al. 1995). However, although this is an area of intense 
research, the extent of said connection remains unknown. During each 
replication event, chromosomes lose DNA at the tips of their chromosomes. 
As they undergo more replication events, chromosomes tend to become 
shorter so, in order to avoid losing valuable coding chromosomal DNA, 
short repetitive non-coding DNA sequences are added to their tips, these 
are called telomeres. Telomeres act as “buffers” during replication, by 
shortening themselves with each division, avoiding loss of important genetic 
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information. But of course, even telomeres would eventually “wear down”, 
so in order to re-elongate them to their original length, an enzyme called 
telomerase is required (Blackburn 1990). Telomeres also prevent 
chromosome fusions that can lead to cancer (DePinho 2000). As a result, 
when telomeres become too short, possibly in order to avoid becoming 
cancerous, cells either stop dividing and enter a senescent state, or self-
destruct through apoptosis (DePinho 2000). Because of this, cells have a 
limited number of divisions they can go through, linked to telomeric length, 
the Hayflick limit (Hayflick 1965). In this sense, telomeres can act as 
biological “clocks”. This idea generated much interest in the aging research 
community, but, despite this, the effect of telomeres and senescence on 
aging remains controversial (Campisi 2005). On the one hand, many lines 
of evidence connect ROS damage to increased senescence and telomere 
shortening (Chen and Ames 1994; von Zglinicki, Saretzki et al. 1995; Oexle 
and Zwirner 1997; Lee, Fenster et al. 1999; Passos, Saretzki et al. 2007), 
providing a potential role for telomeres in aging. On the other hand, 
experiments attempting to establish a causal link between telomere length, 
senescence and aging have come up with unclear results (Gonzalez-
Suarez, Geserick et al. 2005). Overall, the relationship between cancer, 
aging and telomeres is complex and needs further study. 
The ability to guarantee proper protein folding is essential for cellular 
function and organismal viability (Balch, Morimoto et al. 2008). In cells 
undergoing division, damaged and oxidized proteins are retained in mother 
cells, allowing daughter cells a proteomic “fresh start”. However, in post-
mitotic tissues, cells that are not actively dividing, such as neurons, need 
more sophisticated mechanisms to keep their proteome healthy. These 
mechanisms range from protein chaperones to protein degradation 
machinery. Although many proteins fold into their three-dimensional 
structures spontaneously, others require assistance from a sophisticated 
array of enzymes called chaperones. Occasionally, despite these robust 
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chaperoning systems and quality control mechanisms that assure protein 
integrity, polypeptides still fold incorrectly and must be dealt with to avoid 
additional cellular damage. These misfolded or damaged proteins are 
targeted for degradation and degraded by specialized cellular machinery 
(Hebert and Molinari 2007), called proteasomes. However, sometimes, 
misfolded proteins may “escape” degradation by the proteasome. When this 
happens, it can lead to aggregation of misfolded proteins and, 
subsequently, to a “clogging” of the degradation machinery. This, in turn, 
can destabilize the cellular proteome leading to aggregation of other 
unrelated polypeptides (Gidalevitz, Ben-Zvi et al. 2006) and, in severe 
cases, disease. These diseases are collectively known as protein-
aggregation diseases or conformational diseases (Kopito and Ron 2000). 
Among these conformational diseases are human neurodegenerative 
diseases such as Alzheimer’s disease, Parkinson’s disease and 
Huntington’s disease. It is understood that all these diseases involve 
aggregation of specific proteins, however, the specific process by which 
disease develops remains unknown. It is currently accepted that the likely 
culprits are intermediate aggregative oligomeric structures sometimes 
called protofibrils (Caughey and Lansbury 2003; Haass and Selkoe 2007). It 
was initially thought that the easily observable larger cellular aggregates 
were responsible for impairing cellular function (Forloni 1996), but they are 
now believed to serve a protective purpose (Arrasate, Mitra et al. 2004). 
How is this related to aging? The major risk factor for protein aggregation 
diseases is age (Amaducci and Tesco 1994). Individuals containing 
disease-linked mutations manifest the disease in their fifth decade and 
spontaneous aggregation diseases appear in the seventh decade 
(Amaducci and Tesco 1994). Also, C. elegans and mouse transgenic 
models expressing aggregation-prone proteins at a constant level only 
show aggregation at later stages in life (Jankowsky, Savonenko et al. 2002; 
Brignull, Morley et al. 2007). These findings support the notion that the 
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cell’s ability to cope with protein misfolding stress is altered with age. Still, 
the argument could be made that there is a constant accumulation of 
misfolded proteins irrespective of the organism’s age, and that some critical 
mass must be obtained before disease symptoms occur, thus separating 
disease from aging. Interestingly, recent studies contradict this hypothesis. 
In C. elegans, time of onset of aggregation can be delayed by approaches 
that increase longevity, such as inhibiting insulin pathway activity (Morley, 
Brignull et al. 2002; Hsu, Murphy et al. 2003). This is a strong argument for 
a connection between protein aggregation and aging. There are two 
possible explanations for this observation: On one hand, some of the 
factors contributing for aging could also be causing protein aggregation, it is 
tempting to speculate that as organisms age, there is a decrease in quality 
of protein folding mechanisms. On the other hand, protein aggregation itself 
could be causal to aging, as it is already clear that increases in misfolded 
proteins impair organismal function (Hsu, Murphy et al. 2003). In all 
likelihood both of these are accurate to some extent. 
Accumulation of somatic mutations was proposed as another possible 
cause of aging (Miquel 1992; Bohr and Anson 1995; Evans, Burbach et al. 
1995; Morley 1995; von Zglinicki, Nilsson et al. 1995). If we consider cancer 
to be a symptom of aging, then surely mutations play an important role in 
the aging process (Ames, Gold et al. 1995). However, the question 
remains: do somatic mutations play a role in other phenotypes of aging? A 
study showed an age-dependent increase in mutations in a lacZ transgene 
in mouse liver. However, this argument is weakened by the observation that 
mice expressing this same transgene in their post-mitotic brain showed no 
significant increase in mutations (Dolle, Giese et al. 1997). This suggests 
that, although more prominent with age, somatic mutations have little effect 
on an important hallmark of aging organisms, which is age-related 
neurodegeneration. Also, the liver mutations were not dramatic and are 
unlikely per se to have a large effect in the function of the organism (Warner 
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and Johnson 1997). So, what evidence is there supporting somatic 
mutations as a potential cause of aging? A compelling line of evidence is 
the high correlation between DNA repair ability and lifespan (Hart and 
Setlow 1974; Cortopassi and Wang 1996). This is indicative that increased 
DNA repair may play a role in increasing longevity. However, it has been 
demonstrated that effective DNA repair is necessary but not sufficient to 
increase longevity (Hart and Setlow 1974; Cortopassi and Wang 1996). The 
role of somatic mutations and DNA repair mechanisms in aging remains 
controversial. Clearly, organisms need an effective DNA repair system to 
avoid cancer and realize their longevity potential. The question is whether 
this DNA repair system and somatic mutations play a role in normal aging. 
 
1.4 - Modulation of Aging – “Can we age more gracefully?” 
Is aging no more than passive decay of cellular function, much like 
“wear and tear” of an old car? Alternatively, are there biological 
mechanisms regulating aging and if so, can we manipulate them to 
increase longevity? These are key questions in aging research and ones 
that we can begin to address due to work done in the last 20 years. The 
discovery of genetic manipulations capable of extending longevity has 
pushed the aging field from a more descriptive scientific endeavor to one of 
mechanistic, hypothesis-driven work. The discovery that single gene 
mutations in the same genes can extend longevity across different model 
organisms has given much strength to the argument that aging is regulated 
in an evolutionarily conserved way. This, in turn, has fueled the notion that 
potentially, human aging and the onset of age-related disease are 
amenable to manipulation. The possibility of aging-related therapeutics has 
generated much excitement in the field and has fueled the emergence of 
several privately owned companies. Since the discovery, over 20 years 
ago, that genetic manipulations in C. elegans could extend longevity of 
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mutants relative to wild-type (Klass 1983) many more gerontogenes (genes 
affecting longevity) have been identified in worms (Kenyon, Chang et al. 
1993; Lee, Lee et al. 2003; Hamilton, Dong et al. 2005; Hansen, Hsu et al. 
2005). Despite the large number of genes, they can generally be broadly 
grouped into one of three distinct pathways influencing longevity: reduced 
food intake (dietary restriction or DR), reduced insulin signaling or other 
conditions that activate the DAF-16/FOXO transcription factor, or impaired 
mitochondrial function (which is the main focus of this thesis). These three 
pathways have been shown to be conserved in C. elegans and rodents, 
suggesting the presence of an evolutionarily conserved mechanism for 
regulation of lifespan.  
Evidence for the independence of these pathways comes from three 
groups of observations: First, double-mutant analysis shows that the effects 
of these pathways are additive to each other (Lakowski and Hekimi 1998; 
Dillin, Hsu et al. 2002), suggesting they are not acting through the same 
process. Second, the temporal requirements of these three pathways are 
different: loss of insulin signaling during adulthood regulates longevity 
(Dillin, Crawford et al. 2002); mitochondrial impairment has to occur during 
development to increase longevity (Dillin, Hsu et al. 2002); and DR can act 
at any timepoint throughout the animals lifespan to regulate longevity, at 
least in flies (Mair, Goymer et al. 2003). The third set of observations refer 
to transcription factors that are absolutely required for lifespan extension to 
occur in one pathway but are dispensable for longevity in other pathways 
(Lakowski and Hekimi 1998; Houthoofd, Braeckman et al. 2003; Houthoofd, 
Braeckman et al. 2005). Besides increasing lifespan, manipulation of these 
three independent pathways leads to overlapping phenotypes such as: 
resistance to oxidative stress, thermal stress and DNA damage stress 
(Hekimi and Guarente 2003). This prompts the question of whether they are 
merely different upstream regulatory pathways affecting overlapping sets of 
similar downstream effectors. Are there different ways to activate a similar 
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response? In order to address this question we need to understand each of 
these pathways in more detail. Of the three pathways I will provide greater 
background on the mitochondrial inhibition pathway of aging, since it is the 
main point of this thesis. 
 
1.4.1 - Dietary Restriction (DR) 
Over 70 years ago Mcay et al. reported that decreasing food intake 
increased lifespan in rats (McCay, Crowell et al. 1989). Since then, this 
finding has been reproduced in several typical model organisms such as: 
mice (Mair and Dillin 2008), nematodes (C. elegans) (Klass 1977; 
Houthoofd, Braeckman et al. 2003), budding yeast (S. cerevisiae) (Jiang, 
Jaruga et al. 2000), fruit flies (D. melanogaster) (Chapman and Partridge 
1996) and in some more atypical model organisms such as water striders, 
grasshoppers, water fleas, fish, hamsters, dogs and spiders (Mair and Dillin 
2008). Studies on rhesus monkeys (Hansen and Bodkin 1993; Kemnitz, 
Weindruch et al. 1993) and squirrel monkeys (Ingram, Cutler et al. 1990) 
are ongoing and results are promising if still preliminary. In spite of the 
amount of time elapsed since its discovery and its impressive evolutionary 
conservation, the mechanism by which DR acts remains elusive. For many 
years, the field of DR research was lacking molecular studies, probably 
because most studies were done in rodents, which are not as amenable to 
genetic manipulation as some of the invertebrate model organisms.  
Why would decreasing food intake increase longevity? It has been 
proposed that DR may have been evolutionarily selected for, since, during 
low-food situations it delays the onset of reproduction and increases 
longevity. This allows the animals to hold-off committing to the high-energy 
endeavor of reproduction until resources are available (Holliday 1989). This 
increase in energy availability would increase the organism’s chances of 
reproducing successfully and of its offspring surviving. 
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 An argument for DR’s evolutionary conservation is that dietary-
restricted animals share multiple phenotypes across different species in 
addition to the increased longevity. Mainly, as mentioned before, a 
decrease in overall reproductive potential and a delay in onset of 
reproduction have been observed in fruit flies (Mair and Dillin 2008), worms 
(Klass 1977; Bishop and Guarente 2007; Bishop and Guarente 2007) and 
rats (Mair and Dillin 2008). Also, DR in model organisms has been shown to 
delay onset of age-related diseases such as: autoimmune disease, 
osteoporosis, cataracts, neurodegenerative diseases, diabetes and several 
forms of cancer (for a more detailed review see chapter V of Masoro, 2002). 
This means that dietary-restricted animals do not live longer as frail aged 
individuals, but are instead maintained in a healthier state until later in life. 
DR is defined as a significant decrease in caloric intake that does not 
constitute starvation, usually 30-40% lower than fully fed. DR has been 
modeled in many different organisms and in many different ways: from 
decreasing all food availability (Klass 1977; Fabrizio and Longo 2003), to 
specifically altering the animal’s diet (Zimmerman, Malloy et al. 2003; Miller, 
Buehner et al. 2005), to mutations that decrease food intake (Lakowski and 
Hekimi 1998), (for a detailed listing of all, please see (Mair and Dillin 2008)). 
As a consequence of all these different methodologies, results can vary 
significantly between researchers, which has considerably slowed the field. 
The complexity and variability of the response to CR, when administered 
under different conditions, was unexpected. It will be very interesting to 
learn its basis at the molecular level. 
Despite this, progress has been made in understanding the regulatory 
mechanisms of DR. The first potential regulator of DR was discovered in 
budding yeast, it is the NAD+-dependent histone deacetylase SIR2. 
Guarente et al. showed that a mutant yeast strain null for SIR2 were not 
long-lived upon reduction of glucose in the medium, a condition know to 
induce DR (Lin, Defossez et al. 2000). Since then, researchers have shown 
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that overexpression of Sir2p in yeast (Lin, Defossez et al. 2000), worms 
(Tissenbaum and Guarente 2001) and flies (Rogina and Helfand 2004) 
extends longevity, which clearly implicates this conserved family of proteins 
(sirtuins) in aging. However, new lines of evidence have put the initial yeast 
findings into question (Kaeberlein, Kirkland et al. 2004; Kaeberlein and 
Powers 2007), and this, in turn, has significantly weakened the connection 
between DR and sirtuins. Consequently, at this point, the connection 
between sirtuins and DR remains unproven. Another potential modulator of 
lifespan through DR is the target of rapamycin (TOR) pathway (Mair and 
Dillin 2008). The TOR nutrient sensing pathway has been implicated in 
longevity in several model organisms (Schieke and Finkel 2006), and is the 
best candidate for a conserved regulator of DR, found so far. Recently, two 
transcription factors skn-1, which is induced in response to oxidative stress 
(Bishop and Guarente 2007) and pha-4, a forkhead transcription factor 
(Panowski, Wolff et al. 2007) have been identified as necessary for DR-
mediated increased longevity in C. elegans. These are promising molecules 
which may allow genetic probing of DR regulatory pathways. However, it 
remains to be shown whether their effects are conserved across different 
species. Interestingly, recent data has pointed to a role of autophagy in DR-
mediated increased longevity (Jia and Levine 2007; Hansen, Chandra et al. 
2008), this is suggestive that recycling of cellular components has an 
important role in DR and longevity in C. elegans 
 
1.4.2 - Insulin/IGF-1 (IIS) dependent regulation of aging 
The best characterized pathway regulating longevity is the Insulin/IGF-1 
(IIS) dependent regulation of aging. This pathway was originally identified in 
C. elegans (Friedman and Johnson 1988; Kenyon, Chang et al. 1993) 
where it has been studied to the greatest extent. More recent work, points 
to evolutionary conservation in fruit flies (Tatar, Kopelman et al. 2001) and 
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mice (Bluher, Kahn et al. 2003; Holzenberger, Dupont et al. 2003), making 
this an important therapeutic target for longevity modulation in humans 
(Bartke 2008; Suh, Atzmon et al. 2008).  
IIS is an important nutrient-sensing pathway that coordinates processes 
such as development, fat metabolism, growth and reproductive maturation. 
As such, this pathway is a good candidate for regulating longevity in 
response to energy availability, much like what was proposed earlier for 
DR. A possible model is that less energy availability leads animals to post-
pone their reproductive maturation in order to increase likelihood of viable 
progeny (Wolff and Dillin 2006). This is consistent with the function of IIS 
pathway in worms, in that it regulates a hibernation-like state (the dauer 
diapause) that can occur during development if resources are scarce 
(Riddle, Swanson et al. 1981). Animals in this dauer stage are very 
resistant to thermal (Lithgow, White et al. 1995) and oxidative stresses 
(Honda and Honda 1999) and are considerably long-lived. It is all-together 
possible that the long lived C. elegans IIS mutants are activating and 
benefiting from the same protective mechanisms that allow dauers to live 
long, but without the hibernation phenotypes. However, the time during the 
animals’ life when the IIS pathway controls reproduction is different from the 
time when it affects aging (Dillin, Crawford et al. 2002). Also, mutants with 
different alleles have normal reproduction profiles. These are a strong 
arguments against a causal connection between rebroduction and aging . 
In C. elegans the IIS pathway has been thoroughly dissected and most 
of its components identified, for a complete review please see (Kenyon 
2005). The most representative long-lived IIS mutant in C. elegans is daf-
2(-). DAF-2 is the worm’s sole insulin/IGF-1 receptor. C. elegans IIS 
pathway converges on the forkhead transcription factor daf-16, meaning 
that, in the absence of daf-16, daf-2 mutants no longer have increased 
lifespan (Kenyon, Chang et al. 1993). 
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Microrray studies of daf-2(-), daf-16(-) and daf-2(-); daf-16(-) mutants 
showed that the DAF-16 forkhead transcription factor modulates expression 
of several downstream genes affecting longevity (Murphy, et al. 2003). 
Interestingly, individual knock downs of each these genes in long-lived daf-
2 mutants were insufficient to completely suppress longevity. This suggests 
that the total lifespan observed in long-lived daf-2 mutants is a result of 
small cumulative effects from multiple genes downstream of daf-16. 
Therefore, based on this finding, even though aging is regulated by a few 
key pathways, many downstream genes affect longevity. 
Mutations in daf-2 lead to significant metabolic remodeling of the 
organisms as can be ascertained from gene expression studies (Murphy, et 
al. 2003). One interesting change is an increase in expression of enzymes 
necessary for the glyoxylate cycle (Murphy, et al. 2003). The glyoxylate 
cycle is an anaplerotic pathway that feeds intermediates into the Krebs 
cycle, thus allowing production of energy from stored fats. Another 
characteristic of daf-2 mutants is an increase in stress resistance (Larsen 
1993; Vanfleteren 1993; Adachi, Fujiwara et al. 1998), which is 
accompanied by an increase in expression of several stress protective 
genes under control of daf-16 (Vanfleteren and De Vreese 1995; Honda 
and Honda 1999; Murphy, et al. 2003; Lin, Hsin et al. 2001). It is interesting 
to note that, there is a high (albeit imperfect) correlation between longevity 
and stress resistance in most long-lived mutants. This holds true for 
mutants that live long through DR, IIS inhibition or mitochondrial 
impairment.  
In C. elegans germline removal also affects longevity through the daf-16 
forkhead transcription factor (Hsin and Kenyon 1999), and for that reason 
this pathway is discussed in this section. However, this pathway could 
potentially be insulin/IGF-1 independent. Animals missing their germline are 
long-lived in a daf-16 dependent fashion. However, this lifespan is 
synergistic with daf-2, which suggests that these are partially independent 
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pathways. On the other hand, if these animals lack their entire gonad they 
do not exhibit an extended lifespan except when combined with some 
classes of daf-2 mutants, raising the possibility of partial mediation of this 
extension by the IIS (Hsin and Kenyon 1999). These findings support a 
connection between longevity and reproduction, although the nature of this 
connection is still unclear. 
There is also significant evidence that sensory neurons affect longevity 
(Apfeld and Kenyon 1999; Alcedo and Kenyon 2004) in an IIS partially-
dependent fashion. When sensory neuron function is impaired, worms live 
longer (Apfeld and Kenyon 1999). Certain subsets of sensory neurons can 
affect longevity in opposite ways. Different gustatory neurons can both 
extend and shorten longevity in a IIS dependent fashion (Alcedo and 
Kenyon 2004). Olfactory neurons, on the other hand, can affect lifespan in a 
distinct pathway that is connected to the reproductive system (Alcedo and 
Kenyon 2004) and not dependent on insulin signaling. 
 
1.4.3 - Long-lived mitochondrial mutants* 
*(For a summarized version of this section please see section 3.2) 
In section 1.3.2 (Mitochondria and Aging), we showed several lines of 
evidence linking mitochondria to longevity. One of the most compelling 
arguments is that in budding yeast, nematodes and mice, mutations that 
affect normal mitochondrial function can lead to increased longevity. This 
observation in itself is somewhat paradoxical. Since mitochondria and 
mitochondrial respiration are vital processes in cellular metabolism, it is 
unexpected that from their impairment organisms could reap longevity 
benefits.  
In yeast, this phenomenon was initially observed through the usage of 
“petite” strains, these are strains that lack mitochondrial DNA, or fully 
functional mitochondria (Kirchman, Kim et al. 1999). These can occur 
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naturally or be induced through short exposure to ethidium bromide, which 
preferentially inhibits replication of small genomes such as the 
mitochondrial genome (Miceli and Jazwinski 2005). Researchers observed 
that some spontaneous “petite” strains actually had increased longevity. 
Longevity was measured as number of daughter buds per yeast cell, also 
called replicative age (Mortimer and Johnston 1959; Muller, Zimmermann et 
al. 1980), as opposed to chronological age. In this initial work (Kirchman, 
Kim et al. 1999), it is proposed that lack of respiration per se is not the 
cause of the increased longevity. When cells are grown in media containing 
glucose as the carbon source, which under normal circumstances 
represses respiration, they still see an increase in longevity. The authors go 
on to demonstrate that a retrograde response (or retrograde regulation) was 
responsible for the increase in longevity observed in yeast “petites” 
(Kirchman, Kim et al. 1999). Yeast cells with partial or total loss of mtDNA 
(Parikh, Morgan et al. 1987), present altered gene expression profiles. This 
response has been labeled retrograde response (Liao and Butow 1993). 
“Retrograde response” is the general term for mitochondrial signaling and is 
broadly defined as cellular responses to change in the functional state of 
mitochondria. Implicit in this is that this flow of information is opposite to the 
normal anterograde flow of information and proteins form the nucleus and 
cytoplasm into the mitochondria. It is unclear exactly how this flow of 
information occurs, but a few players have already been identified. These 
are RTG1, RTG2 and RTG3 (Chelstowska and Butow 1995), and mutation 
of these genes prevents yeast “petites” from living long (Kirchman, Kim et 
al. 1999). RTG1 and RTG3 encode basic helix-loop-helix leucine zipper 
type transcription factors. They heterodimerize and bind to the promoter 
region of target genes (Liu and Butow 2006). Rtg2p is a cytoplasmic protein 
with an N-terminal ATP binding domain belonging to the actin/Hsp70/sugar 
kinase superfamily (Liu and Butow 2006). It is known that Rtg2p is essential 
for nuclear translocation of the Rtg1p/Rtg3p complex and that the ATP 
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binding domain is essential for this, but the mechanism remains unclear 
(Liu, Sekito et al. 2003). One of the initial markers for the retrograde 
response was increased expression of the gene CIT2, which encodes a 
citrate synthase (Liao, Small et al. 1991), this suggested that there might be 
some form of metabolic response to mitochondrial impairment.  
In order to better understand the underlying cellular processes, two 
genome-wide expression microarray studies comparing respiratory-
competent to respiratory-deficient (“petites”) yeast cells, were completed 
(Epstein, Waddle et al. 2001; Traven, Wong et al. 2001). These studies 
showed significant metabolic and stress response remodeling of the cells 
(Fig. 13). Genes involved in glycolysis were up-regulated (Epstein, Waddle 
et al. 2001; Traven, Wong et al. 2001). One possible explanation for this is 
that, since yeast “petites” are unable to perform respiration, they are likely 
to become increasingly dependent on glycolysis as their main source of 
ATP. Also, there was an increase in expression of many genes either 
directly involved in the Krebs cycle, or in anaplerotic pathways linked to it 
(Epstein, Waddle et al. 2001; Traven, Wong et al. 2001). A potential reason 
for this up-regulation of the Krebs cycle is that respiration-deficient “petites” 
may be compensating for a depletion of cellular glutamate (Fig. 13). 
Glutamate is central to amino acid metabolism and is produced from an 
intermediate of the Krebs cycle, α-ketoglutarate. As a consequence of this, 
treatments that impair the Krebs cycle lead to, among other things, 
depletion of cellular glutamate (Butow and Avadhani 2004). Importantly, the 
Krebs cycle enzyme succinate dehydrogenase is an integral part of the 
electron transport chain (ETC). In the process of converting succinate to 
fumarate, this enzyme donates a pair of electrons to its coenzyme flavin 
adenine dinucleotide (FADH) reducing it. These electrons go on to enter the 
ETC through oxidative phosphorylation. However, if the ETC is non-
functional, there is no way to re-oxidize the coenzyme FAD to its electron 
accepting state. This, in turn means that succinate dehydrogenase is 
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inhibited and the Krebs cycle cannot be completed. In summary, inhibition 
of mitochondrial respiration and electron flow through the ETC, leads to 
interruption of the Krebs cycle and accumulation of succinate. This inability 
of the Krebs cycle to be completed, in turn, leads to a decrease in α-
ketoglutarate availability and to a depletion of cellular glutamate (Butow and 
Avadhani 2004). Hence, it is likely that cells are increasing expression of 
Krebs cycle enzymes and anaplerotic pathways in order to keep the cycle 
flowing, if only partially to allow for production of glutamate. 
These two microarray analyses also showed very significant up-
regulation of glyoxylate cycle enzymes. Glyoxylate cycle is an important 
anaplerotic pathway. It bypasses the succinate-to-fumarate step of the 
Krebs cycle through the formation of glyoxylate, and eventually leads to the 
formation of pyruvate, which can be converted into alpha-ketoglutarate. 
This metabolic process occurs in the peroxisomes (Fig. 13). Another class 
of gene that was seen to have increased expression in these long-lived 
yeast “petites” was the stress response class(Epstein, Waddle et al. 2001; 
Traven, Wong et al. 2001). These stress response genes encoded 
mitochondrial chaperones (Traven, Wong et al. 2001), heat shock proteins 
(Epstein, Waddle et al. 2001; Traven, Wong et al. 2001) and stress 
response transcription factors (Epstein, Waddle et al. 2001; Traven, Wong 
et al. 2001). It is interesting to note that there was one inconsistenciy 
between the two studies, namely Traven et al. found increased expression 
of numerous genes encoding mitochondrial proteins, strongly suggesting 
that the “petites” were trying to compensate for the deficient mitochondrial 
respiration. On the other hand, Epstein et al. saw no change in expression 
levels of these genes. This can potentially be explained by differences in 
the strains used for each study (Butow and Avadhani 2004).  
It is interesting to note that the retrograde response is likely 
evolutionarily conserved, since it has also been described in mammalian 
cells with depleted mtDNA (Miceli and Jazwinski 2005). However, it is 
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unclear whether its role in longevity is specific to yeast, or whether 
retrograde responses can be important processes in regulating longevity of 
other, multicellular, organisms. This question is addressed in chapter III of 
this thesis.  
As important as the yeast work has been in understanding this complex 
relationship between mitochondrial mutants and aging, much work on this 
subject has also been conducted in C. elegans. In fact, the first long-lived 
mitochondrial mutant was identified in the nematodes, clk-1 (Wong, Boutis 
et al. 1995; Lakowski and Hekimi 1996). These mutants were identified as 
long-lived C. elegans mutants (Lakowski and Hekimi 1996) with a particular 
set of phenotypes, namely, that their rates of living were slower than wild 
type’s. These animals took longer to develop to adulthood, and generally 
moved slowly when compared to their wild-type counterparts (Wong, Boutis 
et al. 1995). clk-1 mutants showed decreased rates of pharyngeal pumping, 
defecation and swimming. This gene was later identified to encode a 
mitochondrial hydroxylase necessary for synthesis of ubiquinone, a 
component of the ETC (Ewbank, Barnes et al. 1997). Ubiquinone (Q9; the 
subscript refers to the number of isoprene units) is a prenylated 
benzoquinone lipid required for shuttling electrons from complexes I and II 
to complex III during respiration. In yeast, mutations in COQ7, the yeast 
homologue of clk-1, lead to a loss of viability in the presence of a non-
fermentable carbon source (Jonassen, Marbois et al. 1996). Interestingly, 
despite the likely detrimental effect of this mutation on mitochondrial 
respiration, C. elegans clk-1 mutants are not only viable but also have wild-
type ATP levels (Braeckman, Houthoofd et al. 1999) and close to wild-type 
rates of respiration (Felkai, Ewbank et al. 1999). The reason for this 
difference between C. elegans and S. cerevisiae is that clk-1 mutants can 
compensate for their lack of Q9 with another ubiquinone isoform they obtain 
from their diet, Q8 (Jonassen, Larsen et al. 2001; Larsen and Clarke 2002). 
Like all mitochondrial mutants discovered so far, clk-1(-) animals’ longevity 
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seems independent of DR or the IIS pathways for controlling longevity, 
which sets them up as a bona fide independent pathway for longevity 
regulation. Importantly, clk-1’s role in longevity is likely conserved, since 
heterozygous mice with reduced levels of Mclk-1 live longer than controls 
(Stepanyan, Hughes et al. 2006).  
Another long-lived C. elegans mitochondrial mutant, isp-1, was 
identified in a mutagenesis screen and was found to have several 
phenotypes in common with clk-1(-) animals (Feng, Bussiere et al. 2001). 
These isp-1(-) animals harbor a point mutation in an iron-sulfur protein 
located in complex III of the ETC (Feng, Bussiere et al. 2001). isp-1 
mutants exhibit extraordinarily decreased rates of living and delayed 
development to adulthood (Feng, Bussiere et al. 2001). In many respects 
these mutants have similar, although more dramatic, phenotypes than clk-1. 
However, they differ in a significant trait; isp-1 mutants have a significant 
decrease in mitochondrial respiration as measured by oxygen consumption 
(Feng, Bussiere et al. 2001). Also, as a potential mechanism for their 
increased longevity these mutants are resistant to oxidative damage and 
increase expression of antioxidant enzymes (Feng, Bussiere et al. 2001).  
Recent studies in C. elegans have demonstrated that extreme inhibition 
of mitochondrial function can have detrimental effects and only moderate 
mitochondrial defects lead to increased longevity (Rea, Ventura et al. 
2007). On the other hand, with the advent of RNA interference (RNAi) 
methodology (Fire, Xu et al. 1998; Timmons, Court et al. 2001) it became 
possible to screen whole genome libraries for gene knockdowns that would 
extend longevity. The advantage of such approaches is two-fold: a) 
knockdowns are more likely to be viable than knockouts; and b) since the 
RNAi exposure is achieved through feeding, the animals go through their 
embryonic development with intact function of the gene, thus bypassing a 
sensitive developmental stage. Two separate RNAi screens for genes that 
when knocked down increased longevity of C. elegans identified a very 
 33 
significant role for mitochondrial respiration in lifespan (Dillin, Hsu et al. 
2002; Lee, Lee et al. 2003). These studies showed that knocking down 
several different components of the ETC significantly increased longevity 
and decreased rates of living (Dillin, Hsu et al. 2002; Lee, Lee et al. 2003). 
These phenotypes are similar to the ones observed in clk-1 and isp-1 
mutants. These long-lived mitochondrial RNAi knockdowns were also 
smaller than wild type animals and had decreased ATP production (Dillin, 
Hsu et al. 2002).  
Importantly, when looking at long-lived mitochondrial mutants in C. 
elegans, even though they share several phenotypes, there is an important 
distinction between the ones that do not affect respiration and energy 
production, clk-1 mutants; and the ones that do, isp-1 mutants and RNAi-
induced mitochondrial knockdowns. This has prompted a long-standing 
question in the field, which is: How similar are these long-lived 
mitochondrial mutants to each other? Since they share so many 
phenotypes the simplest explanation is that they share a common 
mechanism in regulating their increased longevities. If so, however, why do 
they have different phenotypes? These questions are addressed in chapter 
III. 
How do these mitochondrial mutations extend lifespan? Because 
mitochondria are the major source of ROS, which could potentially 
accelerate aging, a simple explanation for the increased longevity of 
animals with reduced respiration is that they generate less ROS as the 
animal ages. However, timed RNAi experiments indicate that respiratory-
chain activity must be reduced during development for lifespan extension. 
Adult-only RNAi treatments reduce ATP levels and slow behavioral rates 
but do not extend lifespan (Dillin, Hsu et al. 2002; Rea, Ventura et al. 2007). 
If reducing mitochondrial respiration extended lifespan by reducing the level 
of ROS produced during the aging process itself, then one might expect 
reducing respiration at any time, not only in development, would extend 
 34 
lifespan (Dillin, Hsu et al. 2002). In addition, lifespan extension does not 
correlate with resistance to oxidative stressors (Lee, Lee et al. 2003;Rea, 
Ventura et al. 2007).  
clk-1 mutations, on the other hand, have very little effect on respiration, 
hence it is unlikely they are reducing ROS in this way. Overexpression of 
clk-1 shortens lifespan and increases movement rates in C. elegans (Felkai, 
Ewbank et al. 1999) suggesting that whatever the mechanism, its influence 
on longevity and rates of living is rate-limiting in the animal. However the 
exact mechanism remains elusive. 
In chapter III we present experimental evidence for a likely mechanism 
by which these mitochondrial mutants have increased longevity and 
introduce a potential regulatory pathway governing their mutant 
phenotypes. 
 
1.5 - C. elegans as a model organism for studying 
lifespan regulation – Why old worms? 
The nematode C. elegans as a model organism has pioneered the 
genetic study of aging (Kenyon, Chang et al. 1993; Duhon and Johnson 
1995; Klass 1977). This small nematode has been used in elucidating 
several different biologic phenomena ranging from apoptosis (Ellis and 
Horvitz 1986; Hengartner, Ellis et al. 1992), RNA interference (Fire, Xu et 
al. 1998; Timmons, Court et al. 2001), behavioral neuroscience (Bargmann, 
Thomas et al. 1990) and, more recently, aging. Its genetic tractability, small 
size (I mm in length), and transparency of its outer cuticle (which allows 
visualization of all its 959 cells), have made it an extremely used and useful 
model organism. 
Since the 1960s, when the organism was first chosen as a model 
genetic organism (Brenner 1974), a number of important genes and genetic 
pathways were first identified in C. elegans. Most importantly, several of 
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these have been shown to be evolutionarily conserved in higher organisms. 
Importantly, although the study of the genetic regulation of aging is in its 
relatively early stages, results to date indicate that it is very likely that most 
mechanisms regulating longevity in C. elegans are evolutionarily 
conserved. 
 A relatively short lifespan (the mean lifespan of wild type C. elegans is 
approximately two weeks at 20˚C) and the small size of the animals 
facilitate population studies of longevity. This, in turn, has enabled swift 
progress in identifying and characterizing a number of genes involved in 
lifespan regulation. 
 Some of these genes have proved to be components of known 
regulatory pathways (such as the IIS pathway, see section 1.4.2), while the 
role of others is yet to be clarified. In addition, recent technological 
advances, such as the fully sequenced C. elegans genome (1998) and the 
RNA interference technique (RNAi) (Fire, Xu et al. 1998; Timmons, Court et 
al. 2001), are now allowing the rapid identification of additional longevity 
genes.  
It is particularly important to note that C. elegans, while it is a 
representative of the clade Ecdysozoa whose ancestor diverged from that 
of the vertebrates more than 500 million years ago (Aguinaldo, Turbeville et 
al. 1997), ages in a fashion similar to higher organisms, including humans. 
Older worms exhibit reduced locomotion and their physiological functions 
are slowed down (Johnson, Conley et al. 1988). Moreover, detailed analysis 
of tissue aging in C. elegans has demonstrated that aging nematodes, like 
humans, exhibit sarcopenia, the progressive loss of muscle mass and 
muscle function (Herndon, Schmeissner et al. 2002). In addition, other 
tissues, such as the hypodermis and intestine, also suffer age-related 
damage (Garigan, Hsu et al. 2002; Herndon, Schmeissner et al. 2002). 
Moreover, lipofuscin, a pigment found in “age spots” in humans, 
accumulates in aging worms (Klass 1977). The skin of C. elegans becomes 
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wrinkled and pale as the animal ages. Thus, age-specific tissue 
deterioration gives the animal a characteristic macro- and microscopic 
appearance similar to that of aging humans.  
Mutations that cause increased longevity slow the rates of tissue-
specific aging. For instance, the age-1 mutation (part of the IIS pathway of 
lifespan extension), which extends longevity by approximately 30 to 50% 
and is known to enhance locomotory activity in older animals (Duhon and 
Johnson 1995), delays the onset of age-related sarcopenia (Herndon, 
Schmeissner et al. 2002). Thus, mutations that cause animals to live longer 
than wild type may do so by increasing these animals’ health span. Health 
span can be defined as the amount of time before significant decline of 
physiological function occurs. 
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Chapter II 
Timing of Action of Mitochondrial 
Mutations 
 
2.1 – Summary 
Mitochondrial deficiencies can only increase longevity if caused during 
development. In this section, I identified the developmental time before 
which mitochondrial function must be decreased in order to affect lifespan. I 
found it to be during the L3/L4 stages of post-embryonic development. This 
suggests that the “decision” to live long in response to mitochondrial 
dysfunction occurs late in development, just before the final transition to 
adulthood. 
 
2.2 – Background 
As mentioned in section 1.4.3, mitochondrial knock down using RNAi 
significantly extends longevity, but only if performed during development. 
Inhibiting mitochondrial function during adulthood has no effect on lifespan 
(Dillin, Hsu et al. 2002; Rea, Ventura et al. 2007). This supports the notion 
that the phenotypes observed in these long-lived mitochondrial mutants are 
somehow regulated. If the increase in lifespan was simply due to a passive 
process (such as decreased ROS production) one would expect to see 
some longevity benefit, if only partial, from an adult-only treatment. Bearing 
this in mind, I was interested in understanding the nature of this 
developmental regulatory mechanism.  
During post-embryonic development under well-fed conditions C. 
elegans goes through four different larval molts (L1-L4). During each of 
these stages specific developmental events occur, some of which have 
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been extensively documented. Namely, with regards to mitochondria there 
is a several-fold increase in mitochondrial number during the L3 and L4 
stages, related to sexual maturation (Tsang and Lemire 2003).  
 I was interested in finding the important stage for the “decision” 
regulating longevity in long-lived mitochondrial RNAi-treated animals.  
 
2.3 – Results 
In order to identify the “decision” stage for mitochondrial RNAi mutants, I 
knocked down mitochondrial function at different stages during post-
embryonic development and measured longevity of each population (Fig. 
4). The knockdowns were achieved using an RNAi clone specific for cyc-1, 
which is a component of complex III of the ETC (Dillin, Hsu et al. 2002). The 
experiment was done at two different temperatures (25°C and 20°C) with 
similar results. We found that knocking down mitochondrial function after 
the L3 stage was insufficient to significantly extend longevity (note that we 
are using a p < 0.01 cut-off for significant differences from control). If we 
take into account that RNAi by feeding takes ≈ 8-12 hours to decrease RNA 
levels (Dillin, Hsu et al. 2002; Rea, Ventura et al. 2007), we can estimate 
the important stage for mitochondrial-mediated longevity to be late L3 or L4. 
This is consistent with the observation that when animals were exposed to 
cyc-1 RNAi from hatching they would often develop at a normal rate and 
arrest for several hours at the L4 stage (data not shown).  
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Figure 4 - Mitochondrial knock down after the L3 postembryonic stage is 
insufficient to increase longevity. Tables show the different developmental 
stages at which mitochondrial function was impaired and respective lifespans of 
each population. Greyed lines correspond to non-significant differences relative to 
control. Note that the significance cut-off when comparing to controls is p < 0.01. A 
- Study done at 25°C. Survival graph plots lifespans of populations exposed to cyc-
1 RNAi from hatching (Time 1), only as adults (Time 7) and population exposed to 
control RNAi (Control). Time 1: N = 70; Time 2: N = 72; Time 3: N = 71; Time 4: N = 
71; Time 5: N = 71; Time 6: N = 71; Time 7: N = 71; Control: N = 70. B - Study 
done at 20°C. Survival graph plots lifespans of populations exposed to cyc-1 RNAi 
from hatching (Time 1), as L2s (Time 3), only as adults (Time 7) and population 
exposed to control RNAi (Control). The reason for inclusion of Time 3 was that this 
population was the longest lived. Time 1: N = 60; Time 2: N = NA; Time 3: N = 62; 
Time 4: N = 61; Time 5: N = 60; Time 6: N = 60; Time 7: N = 60; Time 8: N = 63; 
Time 9: N = 60; Control: N = 60. 
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 2.4 – Discussion 
Knocking down mitochondrial function during adulthood has no effect in 
longevity. These experiments show that the decisive stage in the long-life 
response to mitochondrial dysfunction is L3/L4. This is consistent with 
previous work showing a big proliferation of mtDNA during this stage of the 
animals life (Tsang and Lemire 2003), which in turn coincides with 
reproductive maturation. This energy intensive developmental stage is an 
optimal candidate for sensing the ability of cells to produce energy, since it 
is the time where mitochondrial deficiencies would have the most obvious 
consequences.  
Similar findings were published recently (Rea, Ventura et al. 2007), but 
interestingly where these authors report an “all-or-nothing” effect I saw a 
gradual decrease in longevity as mitochondrial function was inhibited closer 
to adulthood. It is interesting to note that when the experiment was done at 
20°C, populations in which the RNAi treatment was started as L2s actually 
lived longer than animals treated from hatching. The reason for this is 
unclear, however it is possible that starting the treatment too early has 
detrimental effects. It is also possible that this result was merely 
experimental variation, since it was not repeated by Rea et. al (Rea, 
Ventura et al. 2007). 
 
2.5 – Methods 
Strains 
The strain used in this study was: N2-Bristol (WT) 
 
RNAi feeding at different developmental times 
Bacterial feeding RNAi experiments were performed as described 
previously (Murphy et al. 2003). cyc-1 RNAi clone was picked from Julie 
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Ahringer RNAi library and confirmed by sequencing. This RNAi clone was 
picked based on experiments from Dillin et al., 2002. Populations were 
synchronized as L1s overnight through larval arrest. Animals were moved 
from a master population exposed to control RNAi, to plates containing 
bacteria expressing cyc-1 dsRNA at different times through development. 
Timepoints were previously determined to reflect all different stages of post-
embryonic development. Each population’s developmental stage was 
determined by visual examination prior to transfer to RNAi treatment. 
 
Survival measurements 
Lifespan analysis was conducted as previously described (Dillin, Hsu et al. 
2002). Assays were done at 20°C and 25°. The Stata 8.0 software package 
(Stata Corporation) was used for statistical analysis and to calculate means 
and percentiles. In all cases p-values were calculated using the logrank 
(Mantel-Cox) method. 
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Chapter III 
A Regulated Longevity Response to 
Mitochondrial Respiration in C. elegans* 
*adapted from Cristina, D., Cary, M., Lunceford, A., Clarke, C., Kenyon, C., 
(2008). A regulated longevity response to mitochondrial dysfunction. PLoS 
Genetics. (Submitted) 
 
3.1 - Summary 
Mitochondrial respiration generates energy in the form of ATP. When 
respiration is inhibited in C. elegans, rates of behavior and growth are 
slowed and lifespan is extended. We find that inhibiting respiration 
increases the expression of genes predicted to protect and metabolically 
remodel the animal. This pattern of gene expression is reminiscent of the 
expression profile of long-lived respiration-defective yeast and mammalian 
cells, the “retrograde response”, suggesting ancient evolutionary 
conservation. As in yeast, genes switched on in C. elegans mitochondrial 
mutants extend lifespan, suggesting an underlying evolutionary 
conservation of mechanism. Mutations in clk-1, which inhibit the synthesis 
of ubiquinone, do not reduce ATP levels, nevertheless they produce gene 
expression, longevity, and behavioral phenotypes similar to those produced 
by inhibiting components of the respiratory chain. We find that knocking 
down the activities of two similar genes, fsrt-1 and fstr-2, partially 
suppresses the phenotypes of clk-1 mutants and inhibits the clk-1(-) 
transcriptional response. Thus, fstr-1/2, which encode potential signaling 
proteins, appear to be part of a mechanism that actively slows rates of 
growth, behavior and aging in response to altered ubiquinone synthesis. 
Unexpectedly, fsrt-1/2 are not required for the longevity and behavioral 
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phenotypes produced by inhibiting the gene isp-1, which encodes a 
component of the respiratory chain. Our findings suggest that different 
types of mitochondrial perturbations activate distinct pathways that 
converge on similar downstream processes to slow behavioral rates and 
extend lifespan.  
 
3.2 - Background 
The link between mitochondria and aging is fascinating and complex. 
Mitochondria generate most of the cell’s energy as well as its reactive 
oxygen species (ROS), and mitochondrial dysfunction can cause disease 
and accelerate aging. Paradoxically, mitochondrial dysfunction can also 
increase longevity. Yeast petite mutants, which lack mitochondrial DNA and 
do not carry out respiration, have an increased replicative lifespan 
(Kirchman, Kim et al. 1999). In C. elegans, two types of mutations that 
affect mitochondrial function also increase lifespan. The first type reduces 
respiration. One such mutant, isp-1(qm150), was identified in an EMS 
screen for mutants with delayed development and defecation rates. These 
animals harbor a mutation in an iron-sulfur protein in complex III of the 
electron transport chain and have reduced rates of oxygen consumption 
(Feng, Bussiere et al. 2001). In addition, two independent RNA interference 
(RNAi) longevity screens found that knock-down of genes encoding 
components of the respiratory chain or ATP synthase decreased ATP 
production and rates of respiration, reduced behavioral rates and increased 
lifespan (Dillin, Hsu et al. 2002; Lee, Lee et al. 2003). Mitochondrial RNAi-
treated animals are smaller than isp-1 mutants (Dillin, Hsu et al. 2002) 
(Hekimi and Guarente 2003), implying either a more severe reduction in 
respiration or, conceivably, a qualitatively different response.  
The second type of mitochondrial mutant is exemplified by clk-1 
mutants, which are also long lived and have reduced behavioral rates 
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(Lakowski and Hekimi 1996). clk-1 mutants lack a mitochondrial 
hydroxylase necessary for synthesis of ubiquinone, a prenylated 
benzoquinone lipid required for shuttling electrons from complexes I and II 
to complex III during respiration (Ewbank, Barnes et al. 1997). In yeast, the 
clk-1 homologue COQ7 is necessary for respiration, and coq7 mutants are 
unable to grow on non-fermentable carbon sources. In contrast, C. elegans 
clk-1 mutants are not only viable, but they have close to normal levels of 
respiration and ATP (Braeckman, Houthoofd et al. 1999; Felkai, Ewbank et 
al. 1999). clk-1 mutants compensate for the lack of endogenous 
ubiquinone, Q9 (the subscript refers to the number of isoprene units) with 
bacterial Q8, provided in their diet (Jonassen, Larsen et al. 2001; Larsen 
and Clarke 2002). In the absence of clk-1, the animals accumulate the Q9 
precursor demethoxyubiquinone (DMQ9). There is some debate over what 
role DMQ9 plays in the clk-1 phenotypes, but the data suggest that they are 
likely due to absence of Q9 (Larsen and Clarke 2002; Branicky, Nguyen et 
al. 2006; Padilla, Jonassen et al. 2004). A role for clk-1 in lifespan 
determination may be conserved evolutionarily, since mice with reduced 
levels of Mclk-1 are also long lived (Liu, Jiang et al. 2005). 
How do these mitochondrial mutations extend lifespan? Because 
respiration is the major source of ROS, which could potentially accelerate 
aging, a simple explanation for the increased longevity of animals with 
reduced respiration is that they generate less ROS as the animal ages. 
However, timed RNAi experiments indicate that respiratory-chain activity 
must be reduced during development for lifespan extension. Adult-only 
RNAi treatments reduce ATP levels and slow behavioral rates but do not 
extend lifespan (Dillin, Hsu et al. 2002; Rea, Ventura et al. 2007). If 
reducing mitochondrial respiration extended lifespan by reducing the level 
of ROS produced during the aging process itself, then one might expect 
reducing respiration at any time would extend lifespan. In addition, lifespan 
extension does not correlate with resistance to the oxidative stressor 
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paraquat (Lee, Lee et al. 2003). Likewise, little is known about the 
mechanism by which clk-1 mutations, which have very small effects on 
respiration, extend lifespan. Overexpression of clk-1 shortens lifespan and 
increases movement rates in C. elegans (Felkai, Ewbank et al. 1999) 
suggesting that whatever the mechanism, its influence on longevity and 
rates of living is rate-limiting in the animal. 
In this study, we have asked how mitochondrial mutations affecting 
respiration and ubiquinone biosynthesis might extend the lifespan of C. 
elegans. It seems possible that these mutations extend lifespan in a similar 
way, since their effects on growth and behavioral rates are so similar. In 
yeast, loss of mitochondrial DNA triggers a robust transcriptional response. 
This change in gene expression is known as a “retrograde response”, so 
named because it implies a reversal in the normal direction of information 
flow between the mitochondria and nucleus (Liao and Butow 1993; 
Kirchman, Kim et al. 1999; Parikh, Morgan et al. 1987). The genes 
expressed during the retrograde response lead to a metabolic remodeling 
of the cell, heat-shock resistance, and increased mitochondrial biogenesis 
(Epstein, Waddle et al. 2001; Traven, Wong et al. 2001; Butow and 
Avadhani 2004; Miceli and Jazwinski 2005). The retrograde response has 
been shown to be required for the increased longevity of these so-called 
yeast “petites”. Thus, lifespan extension in these yeast cells is actively 
regulated, and not simply a passive consequence of decreased respiration. 
Yeast are not the only cells that exhibit a retrograde response to loss of 
respiration. A similar response has been observed in cultured mammalian 
cells when mitochondrial DNA is depleted using ethidium bromide (Miceli 
and Jazwinski 2005). 
The retrograde response may be a compensatory reaction to the normal 
decline in mitochondrial function seen with age, since it is up-regulated in 
older cells (Kirchman, Kim et al. 1999). Whether it could potentially play a 
role in longevity determination in multicellular organisms is not known. 
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Consistent with this possibility, C. elegans isp-1 mutants have increased 
levels of expression of at least one protective gene, the superoxide 
dismutase sod-3 (Feng, Bussiere et al. 2001). In this study, we carried out 
microarray analysis of C. elegans mitochondrial mutants to better 
understand the molecular basis of their longevity. 
 
3.3 - Results 
3.3.1 - clk-1 mutants exhibit a conserved retrograde response 
clk-1 mutations are particularly interesting because their phenotype is 
so enigmatic and their effects on longevity appear to be evolutionarily 
conserved (Liu, Jiang et al. 2005). For gene expression profiling, we grew 
synchronized populations of clk-1(qm30) mutants and wild-type (N2) 
animals and collected them as pre-fertile adults. 1007 genes were deemed 
significant and ranked using the SAM (Significance Analysis of Microarrays) 
tool (Tusher, Tibshirani et al. 2001) using a False Discovery Rate (FDR) of 
~0.1 as cut-off. Interestingly, the majority of the genes in this group (99%) 
were up-regulated relative to wild type, as was also the case in yeast 
petites (Epstein, Waddle et al. 2001; Traven, Wong et al. 2001). The genes 
were analyzed for significant overrepresentation of Gene-Ontology (GO) 
categories using the software BiNGO (Maere, Heymans et al. 2005). 
Several GO categories were overrepresented in clk-1 mutants (Table 1) 
and were related to different cellular processes. From the overrepresented 
GO categories, it appears that clk-1 mutants undergo significant metabolic 
reorganization and activate a stress response similar to that elicited by 
xenobiotics. For example, GO categories 6006, 6007, and 6096 include 
genes involved in glycolysis; GO categories 16835 and 44275 include 
genes potentially involved in glycolysis, gluconeogenesis or anaplerotic 
pathways; GO category 32787 contains genes involved in anaplerotic 
reactions (which generate Krebs cycle intermediates); GO categories 9072, 
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9074 and 30170 encompass genes involved in amino acid metabolism; GO 
categories 6825 and 5375 include genes involved in Cu transport; GO 
category 6629 includes genes involved in lipid metabolism; GO category 
46040 includes genes involved in nucleotide metabolism; and GO 
categories 4499 and 16758 include genes involved in xenobiotic response 
and maintenance of cellular redox state.  
When we looked at the level of individual genes, we observed up-
regulation of genes encoding enzymes required for glycolysis, such as 
GPD-2, GPD-3, (gliceraldehyde 3-phosphate dehydrogenase), T05D4.1 
(Aldolase A homologue), and LDH-1 (lactate dehydrogenase). GEI-7, which 
is an enzyme necessary for the glyoxylate cycle in worms (see section 
3.4.1), was also up-regulated. We also observed increased expression of 
an isocitrate dehydrogenase C30G12.2, likely involved in the Krebs cycle, 
and other alcohol dehydrogenases (dhs-29, dhs-3) that could potentially act 
in anaplerotic pathways. We found increased expression of proteins 
involved in oxidative phosphorylation such as asg-2 (subunit of ATP 
synthase complex) and F17A9.4 (NADH oxidoreductase). Also, several 
genes coding for enzymes involved in amino acid and nucleotide 
metabolism showed increased expression in clk-1 mutants. There was also 
a significant increase in enzymes involved in cellular detoxification, 
including UDP-glycosyl transferases (UGT-53, UGT-13, UGT-43, UGT-6, 
UGT-39), gluthathione S-transferases (GST-4, GST-13, GST-36), 
superoxide dismutase (SOD-3), flavin-containing monooxygenases (FMO-
1, FMO-3) and other gene classes potentially involved in xenobiotic 
metabolism (cytochrome P450s, alcohol dehydrogenases and ABC 
transporters).  
To compare the retrograde response of clk-1 mutants to the yeast 
retrograde response, we referred to two previous publications (Epstein, 
Waddle et al. 2001; Traven, Wong et al. 2001) studying the effects of 
inhibiting mitochondrial respiration in yeast petites. We applied BiNGO 
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software to the most differentially expressed genes reported in those 
studies and compared the results to those of clk-1 mutants. Among the top 
ranking GO categories (p < 0.1), we observed a remarkable degree of 
similarity (p < 0.001) between the clk-1 and yeast petite BiNGO results 
(Table 1). 
 One of the hallmarks of the yeast retrograde response is an increase in 
mitochondrial biogenesis (Biswas, Adebanjo et al. 1999). To test whether 
there was an increase in mitochondrial biogenesis in clk-1 mutants, we 
used Real-Time qPCR to quantify mitochondrial DNA. We observed a 
significant increase in mitochondrial DNA levels (Fig. 5). Together these 
data suggest that clk-1 mutants express a transcriptional response to 
mitochondrial dysfunction that is similar to the yeast retrograde response.  
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Table 1 - Up-regulated GO categories in worm and yeast mitochondrial 
mutants. Tables 1A and 1B show the p-values for the most significant GO 
categories found in isp-1(-), clk-1(-) and cyc-1(RNAi) animals (p < 0.1; FDR < 0.1 in 
at least one mutant) (red represents more significant, yellow represents less 
significant). The “yeast petite” column indicates whether each GO category found in 
one or more of the C. elegans mutants was also overrepresented in petite yeast 
data sets. GO categories are aggregated into GO “branches” (same cell in table) if 
they are part of the same GO hierarchy and are directly related to each other. NS 
represents non-significant, for GO categories that were below our cut-off. NA 
represents not available, for GO categories that had no annotated genes in yeast or 
for situations in which no expression data was available for that category. GO 
categories were separated into two tables (A and B). A. GO categories present in 
two or more C. elegans mitochondrial mutants. All overlap sets, both between 
different combinations of two mutants, as well as between all three mutants, are 
highly significant (p < 0.001). In addition, the number of categories shared between 
all three C. elegans mutants and yeast “petites” is also much higher than expected 
by random (p < 0.001; one would expect 2 categories by random chance) B. GO 
categories present in only one mitochondrial mutant. Categories that were present 
in only one mutant were also less likely to be present in the yeast petite dataset. 
Note that cell-protective genes are not well annotated as distinct GO classes in 
current C. elegans data bases (ie, WormBase). 
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Figure 5 - Mitochondrial DNA quantification. Percent increase in total 
mitochondrial DNA relative to wild type, as measured by qPCR. Data are shown for 
two different mitochondrial primer pairs across five independent biological repeats. 
(*) indicates significance of p < 0.05 after Bonferroni multiple comparison 
correction. Error bars are ± SEM. clk-1(-) primer set A: m (mean) = 1.31 ± 0.07, 
primer set B: m = 1.29 ± 0.08; cyc-1(RNAi) primer set A: m = 1.07 ± 0.03, primer 
set B: m = 1.08 ± 0.03; isp-1(-) primer set A: m = 1.35 ± 0.14, primer set B: m = 
1.21 ± 0.13.  
 
3.3.2 - fstr-1/2 and aqp-1 contribute to the increased longevity of 
clk-1 mutants  
To identify genes necessary for the increased longevity of clk-1(-) 
animals, we compiled a list of differentially expressed genes from 
populations of L4 (late larval stage) as well as prefertile adults (see 
Methods). We included L4 animals in this set because other experiments 
have shown that the L4 period is the critical period for lifespan 
determination in at least some mitochondrial mutants (Rea, Ventura et al. 
2007). We picked the 75 top differentially expressed genes ranked using 
the SAM software package, inhibited their functions using RNAi and 
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measured lifespan. Out of the initial list of 75, we collected lifespan data for 
63 genes over two independent trials. We established a significance cut-off 
of p < 0.05 and selected RNAi clones that decreased clk-1 longevity 
significantly in both trials or were statistically significant in one experiment 
and showed a decrease of at least 5% in the other (a 5% decrease in 
overall lifespan corresponds to an ~25% decrease in the lifespan extension 
produced by clk-1 mutation). We retested the positives in clk-1(-) and wild-
type animals for effects on longevity. Out of 63 RNAi clones tested, only two 
decreased clk-1 mutant longevity in all three trials (Fig. 6). Neither of these 
clones significantly shortened wild-type lifespan, suggesting that they may 
play a role specifically in clk-1 mutant lifespan. One of these clones 
corresponded to aqp-1, which encodes a glycerol channel (Huang, Lamitina 
et al. 2007). aqp-1 RNAi decreased the lifespan extension that would 
normally be produced by clk-1 mutations from 26% to 7%, and did not affect 
wild-type longevity in two separate experiments. Interestingly, aqp-1 (also 
called dod-4) has already been shown to contribute to the long lifespan of 
daf-2 insulin/IGF-1-receptor mutants (Murphy et al. 2003). The other RNAi 
clone, corresponding to a gene we call fstr-1 (for “faster”, also known as gfi-
1) decreased the lifespan extension produced by clk-1 mutations from 26% 
to 3% (close to total suppression on this trial) while not affecting wild-type 
lifespan in two separate experiments. The effects of aqp-1 RNAi and fstr-1 
RNAi on the longevity of clk-1 mutants were tested three times, with 
consistent results, although the extent of suppression varied between 
experiments. We examined the genome for the possibility that fstr-1 RNAi 
might cross-inhibit another gene, and found that the RNAi clone was likely 
to knock down a close homolog (with 98% inferred DNA sequence 
similarity) located next to fstr-1 that did not exhibit clk-1-dependent 
regulation in our microarray analysis. We call this gene fstr-2, and 
henceforth we refer to their combined functions, as inferred from RNAi, as 
fstr-1/2 function.  
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Figure 6 - fstr-1/2 and aqp-1 contribute to the increased longevity of clk-1 
mutants A. aqp-1 RNAi significantly decreased the lifespan extension produced by 
clk-1 mutations from 26% (control) to 7%; p < 0.05, and had no significant effect on 
wild type. WT subjected to control (vector-only) RNAi: N = 103, m = 13.4 days. WT 
subjected to aqp-1 RNAi: N = 106, m = 13.4 days; clk-1(-) subjected to control 
RNAi: N = 105, m = 16.9 days; clk-1(-) subjected to aqp-1 RNAi: N = 105, m = 14.4 
days. Two subsequent independent trials showed a significant decrease in the 
lifespan extension produced by clk-1 mutations (from a 17% to 0% increase and 
from a 33% to 20% increase. B. fstr-1/2 RNAi significantly decreased the lifespan 
extension produced by clk-1 mutation from 26% to 3%, p < 0.05, while having no 
significant effect on wild-type longevity. WT subjected to control RNAi, same as in 
Fig. 2A; WT subjected to fstr-1/2 RNAi: N = 105, m = 13.9 days; clk-1(-) subjected 
to control RNAi: same as in fig.2A; clk-1(-) subjected to fstr-1/2 RNAi: N = 108, m = 
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13.8 days. In two other trials, fstr-1/2 RNAi reduced the lifespan increase produced 
by clk-1 mutations from 33% to 27% (not statistically significant) and from 17% to 
0%. 
 
3.3.3 - fstr-1/2 knockdown increases the behavioral rates of clk-1 
mutants 
In addition to increased longevity, the most striking phenotypes of 
mitochondrial mutants are their decreased behavioral rates. In principle, 
these rates could decrease as a direct consequence of impaired 
mitochondrial function. Alternatively, it is possible that their slowed 
behavioral rates reflect a regulated response to mitochondrial perturbation; 
for example, to conserve energy. To look for genes that slow the behaviors 
of clk-1 mutants, we inhibited the top 100 up-regulated genes from 
microarrays of L4 and pre-fertile adults using RNAi and measured time it 
took for L1 larvae to develop to adulthood. We found that knockdown of fstr-
1/2 in clk-1 mutants consistently increased the rate of growth to adulthood 
(Fig. 7A). This phenotype was most striking when the animals were 
examined 75-80 hours after hatching. At this time, no control animals had 
reached adulthood, whereas 95-100% of the fstr-1/2 RNAi treated animals 
were adults. fstr-1/2 RNAi treatment also increased the behavioral rates of 
clk-1(-) animals, as measured by thrashing and pumping (Fig 7B and 7C). 
These effects were not observed in wild type; in fact, in wild type, knock-
down of these genes had the opposite effect, slowing development and 
decreasing rates of thrashing and pumping.  
Until now, only a few clk-1 suppressors have been found, and these 
were later found to be informational tRNA missense suppressors that 
restored clk-1 function (Branicky, Nguyen et al. 2006). To test whether fstr-
1/2 RNAi somehow restored wild-type clk-1 function, we examined 
ubiquinone profiles. Using HPLC, we observed the expected decrease in 
UQ9 and increase in DMQ9 in clk-1 mutants, and we observed the same 
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mutant pattern of ubiquinone species in clk-1 mutants subjected to fstr-1/2 
RNAi (Fig. 7D). Thus, fstr-1/2 RNAi suppresses the phenotypes of animals 
that have an altered, clk-1(-) pattern of ubiquinone species. This suggests 
that the wild-type fstr-1/2 gene helps to slow behavior and extend lifespan 
in response to the changes in ubiquinone produced by clk-1 mutations. 
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Figure 7 - fstr-1/2 RNAi speeds up clk-1(-) animals. A. Time to adulthood. clk-1 
mutants take much longer to reach adulthood than wild-type animals. This rate of 
development is accelerated by fstr-1/2 RNAi. In contrast, fstr-1/2 RNAi slowed the 
growth rate of wild type. These effects were very robust and were observed in 
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every experiment. WT subjected to control RNAi: 47.4 ± 1.6 hours; WT subjected to 
fstr-1/2 RNAi: 53.2 ± 1.7 hours; clk-1(-) mutants subjected to control RNAi: 82.2 ± 
1.2 hours; clk-1(-) mutants subjected to fstr-1/2 RNAi: 72 ± 1.7 hours. B. Boxplots 
illustrating thrashing rates measured on day 3 of adulthood. fstr-1/2 RNAi treatment 
significantly reduced the average thrashing rate of wild-type animals and 
significantly increased the average thrashing rate of clk-1(-) mutants. WT subjected 
to control RNAi: 115.6 ± 3.1 thrashes/min; WT subjected to fstr-1/2 RNAi: 97.5 ± 
4.3 thrashes/min; clk-1(-) mutants subjected to control RNAi: 61.2 ± 5 thrashes/min; 
clk-1(-) mutants subjected to fstr-1/2 RNAi: 78.9 ± 5.7 thrashes/min. C. Boxplots 
illustrating pumping rates. fstr-1/2 RNAi decreased the average pumping rate of 
wild type and increased the pumping rate of clk-1(-) mutants. WT subjected to 
control RNAi: 273.3 ± 41.1 pumps/min; WT subjected to fstr-1/2 RNAi: 231.8 ± 24.7 
pumps/min; clk-1(-) mutants subjected to control RNAi: 188.5 ± 41 pumps/min; clk-
1(-) mutants subjected to fstr-1/2 RNAi: 238.9 ± 36.4 pumps/min. In figures 3A, 3B 
and 3C error bars depict SEM; * depicts a significance of p < 0.05 when compared 
to controls, ** depicts significance of p < 0.008 when compared to controls, ¥¥ 
depicts significance of p < 0.008. P < 0.008 is the cut-off set by the Bonferroni 
correction for multiple comparisons. D. HPLC analysis of quinone content. The 
chromatograms show a representative run of three independent experiments for 
each of the different conditions (WT subjected to control RNAi, WT subjected to 
fstr-1/2 RNAi, clk-1(-) mutants subjected to control RNAi and clk-1(-) mutants 
subjected to fstr-1/2 RNAi). The Q9 peak is absent from clk-1(-) animals and 
instead the intermediate DMQ9 is detected. fstr-1/2 RNAi had no effect in Q9 levels 
in wild-type or clk-1(-) mutants, in clk-1 mutants Q9 levels remained below detection 
threshold. 
 
3.3.4 - fstr-1/2 is necessary for gene expression changes 
observed in clk-1 mutants 
Next we asked whether FSTR-1/2 modulates the clk-1 mutant 
phenotype by influencing the retrograde response. Using real-time qPCR, 
we looked at the effects of fstr-1/2 RNAi on the expression levels of five of 
the genes whose expression was most significantly up-regulated genes in 
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the microarrays: gpd-2, a glyceraldehyde 3-phosphate dehydrogenase 
involved in glycolysis; T22B7.7, an Acyl-CoA thioesterase, involved in 
anaplerotic reactions; dhs-26, an alcohol dehydrogenase; ugt-43, an UDP-
glucoronosyl transferase; and the aquaporin gene aqp-1. The qPCR data 
confirmed the microarray studies, in that all of these genes were up-
regulated in clk-1 mutants. We found that fstr-1/2 RNAi significantly and 
consistently decreased expression of these genes in a clk-1(-) background 
(Fig. 8A) but not in wild type (Fig. 8B). Thus, the gene expression changes 
observed in clk-1 mutants are at least partially dependent on fstr-1/2. 
Together these findings suggest that fstr-1/2(+) controls rates of behavior 
and lifespan in clk-1 mutants by triggering downstream changes in gene 
expression.  
 60 
Figure 8 - fstr-1/2 RNAi inhibits expression of the clk-1 retrograde response. 
A - The graph shows the effect of fstr-1/2 RNAi on the degree of up-regulation of 
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individual clk-1 retrograde-response genes, as determined by quantitative RT-PCR. 
(**) represents a significance of p < 0.01, (*) represents a significance of p < 0.05, 
in comparing mRNA levels from clk-1(-); fstr-1/2(RNAi) animals vs. clk-1(-) control 
animals. Each bar represents the average of 3 independent biological repeats. 
Error bars are ± SEM. clk-1(-) animals subjected to control RNAi (grey bars) 
showed significantly higher expression than did wild type subjected to control RNAi 
(p < 0.05) for all genes tested. With the exception of gpd-2 all genes showed a 
significant decrease in expression (p < 0.05) in the presence of fstr-1/2 RNAi. Note 
that gpd-2 shared the trend, with p = 0.061, and was clearly affected when assayed 
using the Pgpd-2::gfp reporter in vivo (Fig. 12) B - Retrograde-response genes 
respond differently to fstr-1/2 RNAi in wild-type animals and clk-1 mutants. The 
graph shows the effect of fstr-1/2 RNAi on the degree of up-regulation of individual 
clk-1 retrograde-response genes, as determined by quantitative RT-PCR in a wild 
type background. (*) represents a significance of p < 0.05, in comparing mRNA 
levels from wild type animals subjected to fstr-1/2(RNAi) vs. wild type control 
animals. Each bar represents the average of 3 independent biological repeats. 
Error bars are ± SEM. With the exception of T22B7.7, fstr-1/2(RNAi) did not knock 
down expression of any of these genes in a wild type background. 
 
3.3.5 - fstr-1 may act in the intestine and/or nervous system to 
slow down clk-1 mutants 
Because fstr-1 is up-regulated in clk-1 mutants, we were particularly 
interested to learn where in the animal it was expressed. To investigate this, 
we generated transgenic animals expressing the fluorescent protein 
mCherry under the control of the fstr-1 promoter. We observed strong 
expression in three neurons located in the head and throughout the 
intestine, particularly in the anterior cells (Fig. 9). The three neurons were 
identified as RIH and I1L/R. RIH neuron is a nerve-ring interneuron of 
unknown function and I1L/R are pharyngeal interneurons that regulate 
pharyngeal pumping rates in response to touch and in the absence of 
bacteria (Avery L, and Thomas J. H., 1997, C.elegans II). We saw the same 
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pattern of expression in clk-1(-) and wild-type, but the intensity of 
expression was increased in the mutant, consistent with our qRT-PCR and 
microarray data. Together these findings suggest that fstr-1 acts in the 
intestine and/or in specific neurons to slow the rates of aging and behavior 
in clk-1 mutants.  
 
 
Figure 9 - fstr-1 is expressed in the intestine and three neurons in a clk-1(-) 
background. A Pfstr-1::mCherry promoter fusion is expressed in the intestine, 
especially in anterior cells, as well as in RIH and I1L/R neurons. Small arrows point 
to cell bodies of I1L/R neurons with their characteristic processes visible; large 
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arrows point to the cell body of the RIH neuron. The small panel shows a more 
detailed view of RIH neuron. Scale bar represents 20 µm.  
 
3.3.6 - A similar retrograde response in animals with reduced 
respiration  
To compare the pattern of gene expression in clk-1 mutants to that of 
mutants with reduced rates of respiration, we performed microarray 
analysis of isp-1(qm150) and cyc-1(RNAi) (cytochrome c) animals. cyc-1 
encodes a cytochrome c reductase which is a component of complex III of 
the electron transport chain. We grew synchronized populations of isp-
1(qm150) and cyc-1(RNAi) mutants in parallel with wild-type control 
animals, collected the animals as young, pre-fertile adults and analyzed the 
resulting microarray data as described above for clk-1 mutants. The SAM 
algorithm with a FDR of ~0.1 yielded 814 significant genes for isp-1(-) 
mutants and 7662 significant genes for cyc-1(RNAi) animals. Thus, it 
seems that cyc-1 RNAi induces a broader transcriptional response than do 
clk-1 and isp-1 mutations, which correlates with the increased severity of 
the Cyc-1(RNAi) phenotype. In addition, cyc-1 RNAi-treated animals, when 
compared to isp-1 and clk-1 mutants, showed increased expression of 
additional cell-protective genes, including chaperones (hsp-6, hsp-70), 
superoxide dismutases (sod-4, sod-3) and xenobiotic detoxification 
enzymes (ugt-2, ugt-47, ugt-36, gst-8, gst-22, gst-24, dhs-5, dhs-28). 
Interestingly, other genes encoding detoxification enzymes were down 
regulated, possibly implying the deployment of a specific detoxification 
program. Using BiNGO analysis, we identified several GO categories that 
were overrepresented in each mutant (Table 1). A highly significant fraction 
of the top GO categories (p < 0.1) were shared between either two, or all 
three, of the mutant strains (p < 0.001; Table 1). By chance, one would 
expect 2 of the 10 GO categories shared by all three mitochondrial mutants 
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and annotated in yeast to also be significant in the yeast petite cells; in 
contrast, we observed 8 categories in common (p < 0.001). 
In addition to identifying GO categories, we looked for individual genes 
that were expressed in a similar way in the three C. elegans mitochondrial 
mutants. We found a highly significant (p = 7.19E-15) overlap set of 73 
differentially-expressed genes (Table 2). In addition, we observed an 
increase in mitochondrial biogenesis in isp-1 mutants and a smaller 
increase in cyc-1(RNAi) animals that did not reach statistical significance (p 
= 0.354) (Fig. 5). Taken together, these data suggest that the retrograde 
responses of different C. elegans mitochondrial mutants are similar to one 
another and to the yeast retrograde response. 
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Table 2. The most significant differentially-expressed genes overlapping 
between isp-1, clk-1 and cyc-1(RNAi) mutants. The set of overlapping genes 
was determined using the “p-q” algorithm (see Methods), using the combined set of 
L4 and adult microarray data as input. Significance values shown were calculated 
using the SAM software package, also run on the combined set of L4 and adult 
data. The top 30 genes listed were tested for suppression of lifespan extension in 
isp-1 mutants. Also shown are the SAM significance values for these genes using 
the adult-only set of chips. 
 
3.3.7 - cdr-2 RNAi suppresses the increased longevity of isp-1 
mutants 
`Since isp-1, clk-1 and cyc-1(RNAi) mutants are all long-lived, gene 
expression patterns that are shared between all three might be particularly 
likely to contribute to lifespan extension. Double RNAi experiments in C. 
elegans can be difficult to interpret, so we did not attempt RNAi 
knockdowns in cyc-1(RNAi) animals. However, we did attempt to knock 
down the top thirty statistically-significant shared genes, individually, in an 
isp-1 background (of these, 21 were not present in the clk-1 set we 
described above). We obtained data for 30 of these genes. Of these, only 
one RNAi clone, cdr-2, consistently made our significance cut-off [p < 0.05 
and a 10% decrease in isp-1 mutant longevity (which corresponds to a 50% 
decrease in the lifespan extension produced by the isp-1 mutation)]. cdr-2 
RNAi reduced the lifespan extension produced by the isp-1 mutation from 
43% (control RNAi) to 26%, while not affecting wild-type longevity (Fig. 10).  
cdr-2 encodes a member of the glutathione S-transferase family. These 
enzymes catalyze the conjugation of reduced glutathione to electrophilic 
centers on different substrates. This activity contributes to detoxification of 
both endogenous toxins and xenobiotics, suggesting that the increased 
longevity of isp-1(-) mutants is at least partially dependent on a cellular 
detoxification response. We note that in one of our three trials, cdr-2 RNAi 
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significantly shortened the lifespan extension produced by clk-1-mutation 
(from 21% to 14% longer than wild type). This finding suggests that cdr-2 
may be involved more generally for lifespan extension in mitochondrial 
mutants. 
 
 
Figure 10 - cdr-2 RNAi suppresses the increased longevity of isp-1 mutants. 
cdr-2 RNAi suppressed the longevity increase produced by isp-1 mutation from 
43% to 26% (p < 0.05) and did not significantly affect wild-type longevity. WT 
subjected to control RNAi: N = 90, m = 18.1 days; WT subjected to cdr-2 RNAi: N = 
87, m = 19.1 days; isp-1(-) subjected to control RNAi: N = 89, m = 22.4 days; isp-1 
(-) subjected to cdr-2 RNAi: N = 89, m = 20.1 days. In a second trial, cdr-2 RNAi 
decreased the lifespan extension produced by isp-1 mutation from 24% to 11% (p < 
0.05). Lifespans were determined at 20°C.  
 
3.3.8 – fstr-1/2’s regulatory function is specific to clk-1 mutants  
Given the remarkable reversal of the clk-1 mutant phenotype by fstr-1/2 
RNAi, we were interested in examining its function in respiration-defective 
mutants. Unexpectedly, we found that fstr-1 was significantly up-regulated 
in isp-1 mutants but not in cyc-1(RNAi) animals. Using RNAi, we asked 
whether fstr-1/2 might influence the behavioral phenotypes of isp-1(qm150) 
mutants. We restricted our analysis to lifespan and time to adulthood 
because isp-1 mutants did not move often enough to provide consistent 
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behavioral rates. We found that the development rates of isp-1 mutants 
were severely decreased in the presence of fstr-1/2 RNAi, leading to 
developmental arrest of many animals. We found that fstr-1/2 RNAi had no 
effect on the lifespan of isp-1 mutants that reached adulthood (Fig. 11). 
Thus the effect of fstr-1/2 RNAi on isp-1 mutants was more similar to the 
effect of fstr-1/2 RNAi on wild type than to its effect on clk-1 mutants.  
We wanted to know whether fstr-1/2 was necessary for gene expression 
changes in an isp-1(-) background, but because isp-1 mutants subjected to 
fstr-1/2 RNAi grew very slowly and asynchronously, we could not use qRT-
PCR. Instead, we assayed gene expression in vivo by introducing the isp-1 
mutation into a strain expressing GFP under the control of the gpd-2 
promoter, which drives expression of a glycolysis gene that is up-regulated 
by mitochondrial mutations (Fig. 12). We found that fstr-1/2 RNAi prevented 
the up-regulation of this reporter in a clk-1 background but not in an isp-1 
background. Together, these data suggest that the Isp-1(-) and Clk-1(-) 
behavioral and longevity phenotypes are established by distinct 
mechanisms. 
 
 
Figure 11 - fstr-1/2 RNAi did not shorten the lifespan of isp-1 mutants. isp-1(-) 
subjected to control RNAi: N = 108, m = 24.6 days; isp-1 (-) subjected to fstr-1/2 
RNAi: N = 104, m = 23.6 days. These experiments were repeated twice more with 
similar results (Sup. Table 4). 
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Fig. 12. fstr-1/2 RNAi does not affect gpd-2 expression in an isp-1 mutant. 
Worms harboring a Pgpd-2::GFP promoter fusion were ranked as: Dim 
Fluorescence, Medium Fluorescence and High Fluorescence based on visual 
inspection. Each bar represents a different population (N = 80 worms). Two 
separate observations were made for each condition. 
 
3.4 - Discussion 
How inhibiting something as fundamental as mitochondrial function can 
extend lifespan is a profoundly interesting question. C. elegans respiration 
mutants appear to live in “slow motion”, as the rates of a wide variety of 
processes, including rates of growth to adulthood, aging and behavior, are 
all reduced. This phenotype is shared by clk-1 ubiquinone-biosynthetic 
mutants, which, paradoxically, show only a very mild and temporary 
decrease in respiration, and have normal ATP levels (Braeckman, 
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Houthoofd et al. 1999). This spectrum of behavioral and longevity 
phenotypes is not seen in the many C. elegans mutants whose longevity 
requires the transcription factor DAF-16, or in calorically restricted animals, 
so these mitochondrial mutants appear to comprise a distinct class of 
longevity mutants. Reducing clk-1 activity extends the lifespan of mice, 
suggesting that a better understanding of these mutants could potentially 
have implications for human health and longevity.  
In this study, we used microarray analysis and RNAi to investigate the 
mechanisms by which these various mitochondrial mutations acquire their 
distinctive behavioral and longevity phenotypes. 
 
3.4.1 - A C. elegans retrograde response 
 Gene expression profiling of these mutants was quite revealing, 
because each of their expression profiles exhibited striking similarity to the 
yeast retrograde response. In yeast, the retrograde response appears to 
remodel the cell’s metabolism. Without respiration, the Krebs cycle cannot 
be completed, as succinate cannot be oxidized to fumarate (Fig. 13). This 
prevents the formation of oxaloacetate (OAA), which in turn decreases the 
availability alpha-ketoglutarate, which is the precursor of glutamate, an 
essential metabolite in amino acid metabolism. In order to recycle the 
precursors of glutamate, respiration-deficient cells must activate alternative 
(anaplerotic) pathways that supply the mitochondria with OAA and acetyl-
CoA (Butow and Avadhani 2004). Activation of anaplerotic pathways was 
observed in respiration-defective yeast (Epstein, Waddle et al. 2001; 
Traven, Wong et al. 2001) and human cells (Miceli and Jazwinski 2005).  
Our microarrays reveal activation of several metabolic enzymes that 
have roles in anaplerotic reactions, such as the glyoxylate cycle and fatty 
acid oxidation. The glyoxylate cycle occurs mainly in the peroxisomes and 
bypasses the succinate-to-fumarate step of the Krebs cycle through the 
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formation of glyoxylate, eventually leading to the formation of succinate, 
which can be fed back into the Krebs cycle (Fig. 13). We observed 
increased expression of the gene encoding the major C. elegans 
glyoxylate-cycle enzyme, GEI-7, in the three mitochondrial mutants we 
examined. We did not observe an RNAi phenotype for this clone in the clk-1 
mutant; however, because a gei-7 mutant was available, we examined cyc-
1(RNAi); gei-7 animals and found a large suppression of the cyc-1(RNAi) 
longevity phenotype, decreasing lifespan extension from 80% to 15% with 
little effect on wild type (Sup. Fig. 3). Malate dehydrogrenases catalyze 
synthesis of OAA from malate, which is also an important step in recycling 
Krebs cycle intermediates. F46E10.10 encodes a malate dehydrogenase 
and is significantly up-regulated in all three long-lived mitochondrial mutants 
we examined. Fatty-acid oxidation provides acetyl-CoA, which feeds into 
the Krebs cycle by reacting with OAA to form citrate. This pathway is 
activated in long-lived yeast lacking mitochondrial DNA (Butow and 
Avadhani 2004). We also detected increased expression of several genes 
that are involved in fatty acid oxidation. clk-1(-) animals exhibited increased 
expression of acs-2 (acetyl-CoA synthetase ) and fat-6 (fatty acid 
desaturase); and isp-1 mutants increased expression of T02G5.4 (acetyl-
CoA thiolase) and T05G5.6 (Enoyl-CoA hydratase). The expression profiles 
of cyc-1(RNAi) animals, however, contained fewer significant genes 
involved in fatty acid oxidation, suggesting there may be some differences 
in metabolic adjustments between different mitochondrial mutants.  
In all three long-lived mitochondrial mutants, we observed a significant 
increase in expression of genes involved in glycolysis. This was expected, 
since glycolysis becomes a more important source of ATP when oxidative 
phosphorylation is inhibited.  
In addition to these metabolic shifts, we also observed increased 
expression of a significant number of stress response genes in all three 
mitochondrial mutants, ranging from genes increasing xenobiotic drug-
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resistance to protein chaperones. This is consistent with previous in vitro 
observations that impairment of electron flow during oxidative 
phosphorylation is actually likely to generate more ROS (Lenaz 2001), and 
suggests these animals may be responding to this additional cellular insult. 
Finally, in all three strains, genes involved in the oxidative 
phosphorylation process itself were up-regulated, and we observed 
increased levels of mitochondrial DNA in clk-1 and isp-1 mutants. Thus, 
apparently C. elegans mitochondrial mutants, like yeast (Traven, Wong et 
al. 2001), attempt to compensate for reduced mitochondrial efficiency. 
Together these findings show that the retrograde response triggered in C. 
elegans is very similar to the one present in long-lived respiration-defective 
yeast and suggest the presence of a conserved pathway regulating 
longevity in response to mitochondrial dysfunction. 
While this manuscript was in preparation, Falk et al. reported the gene 
expression pattern of a mixture of long-lived and short-lived respiration-
defective mutants compared to wild type (Falk, Zhang et al. 2008). In the 
future, it will be interesting to learn whether the expression patterns of 
short-lived mitochondrial mutants differ from those of the long-lived 
mutants. The lifespan of one such short-lived mutant, mev-1(kn1) is 
increased when respiration is lowered further using respiratory-chain RNAi 
(Fig. 14), arguing that their short lifespans are not due simply to insufficient 
respiratory-chain activity. 
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Figure 13 - C. elegans retrograde response. The picture diagrams metabolic 
changes thought to occur during the yeast retrograde response (Butow and 
Avadhani 2004). “++” indicates that these same changes are observed in the C. 
elegans retrograde response; Impairment of electron flow during oxidative 
phosphorylation is predicted to have two effects. The first is an increase in ROS, 
due to increased likelihood of electrons transferring to free oxygen (Lenaz 2001). 
Consistent with increased ROS stress (which we did not assay directly), we 
observed an increase in cell-protective genes. Secondly, the Krebs cycle is 
disrupted because the enzyme succinate dehydrogenase is an integral part of both 
the electron transport chain and of the Krebs cycle. When succinate 
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dehydrogenase oxidizes succinate into fumarate it feeds electrons into the ETC, 
and when this flow is blocked, the enzyme’s activity is inhibited. The Krebs cycle is 
necessary for synthesis of glutamate, which in turn is required for amino acid 
metabolism. Impairment of the electron transport chain leads to decreased 
glutamate production. Possibly, in order to counteract this decrease in glutamate 
production, the cell induces anaplerotic pathways that feed intermediates into the 
Krebs cycle, thus allowing production of glutamate. Under conditions of impaired 
respiration, glycolytic gene expression increases, consistent with glycolysis’ 
becoming a major source of ATP. Consistent with a compensatory response, 
expression of genes involved in oxidative phosphorylation is up-regulated. OAA, 
Oxaloacetate; GLU, glutamate; ETC, electron transport chain; α-KG, α-
ketoglutarate.  
 
 
Figure 14 - The short lifespan of mev-1 mutants is increased by respiratory-
chain RNAi. WT subjected to cyc-1 RNAi: N = 81, m = 27.6 days; WT subjected to 
control RNAi: N = 81, m = 19.7 days; mev-1(kn1) mutants subjected to cyc-1 RNAi: 
N = 80, m = 16.7 days; mev-1(kn1) mutants subjected to control RNAi: N = 78, m = 
13.2 days. This lifespan analysis was performed twice, p < 0.001 both times. 
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3.4.2 - Long-term reductions in respiration are not necessary to 
maintain expression of the retrograde response 
It was interesting to find that clk-1 mutations trigger a conserved 
retrograde response even though they only have a mild effect on 
respiration. There are at least two possible interpretations for this finding. 
The first is that the retrograde response need not be triggered by reduced 
respiration itself, but instead can be triggered by signals that are generally 
associated with reduced respiration, such as fluctuations in ubiquinone 
levels. Such fluctuations could have acquired the ability to induce the 
retrograde response during evolution because they allowed the animal to 
conserve energy in the face of a perceived energy shortage. Alternatively, 
perhaps the clk-1 mutation does inhibit respiration initially, but the 
physiological changes elicited by the retrograde response (such as 
increased mitochondrial biosynthesis), restore the steady-state level of 
respiration to normal.  
 
3.4.3 - The retrograde response is probably required for the 
longevity of C. elegans mitochondrial mutants. 
In yeast, the retrograde response is induced via helix-loop-helix 
transcription factors that do not appear to be present in C. elegans. When 
the genes encoding these transcription factors are deleted in yeast, 
inhibiting respiration does not induce the retrograde response, and lifespan 
is not extended (Kirchman, Kim et al. 1999). Thus, in yeast, the retrograde 
response likely increases lifespan. Our data suggest that this is the case in 
this multicellular animal as well. First, inhibiting the activity of at least some 
of the genes up-regulated in mitochondrial mutants was sufficient to shorten 
their lifespan without obviously affecting the lifespan of wild type. In 
particular, the glutathione S-transferase gene cdr-2 was up-regulated in all 
of the long lived mutants and it contributed to lifespan extension 
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consistently in isp-1 respiration-defective mutants and, at least in some 
trials, in clk-1 mutants as well. This finding suggests that the prominent cell-
protective gene expression response that we observe contributes to 
longevity. In addition, the metabolic shifts we observed are also likely to 
influence lifespan, as the longevity of cyc-1(RNAi) animals required the 
glyoxylate-cycle gene gei-7 (Fig. 15). 
Our failure to observe effects on lifespan with most of the RNAi clones 
we tested does not necessarily mean that they do not influence lifespan 
(though this may be the case). It seems likely that many of these genes 
would act cumulatively to influence lifespan. The lifespan extension of clk-1 
and isp-1 mutants was only ~20% in most experiments, so only 
perturbations that are fairly strong would be visible in our assays.  
The second argument for the importance of the C. elegans retrograde 
response in the longevity of mitochondrial mutants comes from our studies 
of fstr-1/2. fstr-1 was up-regulated in clk-1 mutants, and this gene, and/or its 
constitutively-expressed homolog fstr-2, is required, in turn, for a robust 
retrograde response. Knocking down fstr-1/2 activity with RNAi did not 
suppress the primary ubiquinone defect. However, none of the five up-
regulated genes we tested was up-regulated in the presence of fstr-1/2 
RNAi. These genes included metabolic as well as cell-protective genes, 
arguing that fstr-1/2 is a major regulator of the retrograde response in clk-1 
mutants. This restoration of a normal transcriptional profile correlated with a 
suppression of the behavioral, growth and longevity phenotypes of clk-1 
mutants. Together all of these findings support the hypothesis that the 
conserved mitochondrial retrograde response extends lifespan in 
metazoans as well as in yeast. We note, however, that fstr-1/2 RNAi had 
stronger effects on the induction of the retrograde-response genes we 
tested than it had on the clk-1 behavioral phenotypes. This suggests either 
that part of retrograde response is expressed independently of fstr-1/2, or 
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that mechanisms that do not involve transcription also influence the clk-1 
phenotype. 
 
 
Figure 15 - The glyoxylate cycle gene gei-7 is partially necessary for cyc-1 
RNAi to increase longevity. WT subjected to cyc-1 RNAi: N = 109, m = 40.1 days; 
WT subjected to control RNAi: N = 113, m = 22.3 days; gei-7(ok531) mutant 
subjected to cyc-1 RNAi: N = 118, m = 26.6 days; gei-7(ok531) mutant subjected to 
control RNAi: N = 119, m = 22.1 days. This lifespan analysis was performed twice, 
p < 0.001 both times. 
 
3.4.4 - The molecular function of FSTR-1/2 
How does FSTR-1/2 regulate gene expression? Little is known about 
the molecular function of FSTR-1/2. FSTR-1/2 contains 21 ET modules, 
which are domains of unknown function containing 8-10 conserved 
cysteines predicted to form 4-5 disulphide bridges. Sequence alignment 
studies using the BLAST algorithm showed weak similarities to a secreted 
yeast protein (AGA1) and a predicted mouse membrane protein 
(Zonadhesin); however, we found no clear secretion signal or 
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transmembrane domain. We also looked for structural homologues of fstr-
1/2 using the software package PHYRE (Bennett-Lovsey, Herbert et al. 
2008) and found highly significant predicted structural similarities to portions 
of ErbB1/2/3/4. ErbB proteins belong to a highly conserved family of 
receptor tyrosine kinases that play many roles in cell biology and disease. 
Members of the ErbB family usually contain an extracellular region (~ 620 
amino acids) that recognizes and binds ligands, a single membrane 
spanning region and an intracellular tyrosine kinase domain. However, we 
did not find a predicted tyrosine kinase domain or a secretion signal in fstr-
1/2’s sequence, which makes a potential connection to the ErbB family 
unclear. Finally, FSTR-1 (originally called GFI-1, for GEX-interacting 
protein) was identified in a two-hybrid screen as a potential binding partner 
of UNC-68, a muscle-specific C. elegans ryanodine receptor. Our attempts 
to find phenotypic similarities or functional interactions between these two 
proteins were unsuccessful (data not shown), so their potential relationship 
remains unclear. 
Our findings suggest that FSTR-1 expression in the intestine and/or 
nervous system may influence the longevity of clk-1 mutants. Because the 
whole animal is affected by the clk-1 mutation, it is likely that FSTR-1 either 
is, or controls, a secreted signal that regulates the physiology of the entire 
animal. Alternatively, perhaps FSTR-2 acts in other tissues to influence 
lifespan. An attractive model would be that changes in ubiquinone synthesis 
activate expression of fstr-1 in neurons and intestine. FSTR-1 (and possibly 
also FSTR-2) then activate the broader retrograde response, which in turn 
reduces growth and behavioral rates and extends the lifespan of the animal 
(Fig. 16). 
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3.4.5 - Different paths to a similar phenotype  
Long-lived C. elegans mitochondrial mutants share many phenotypes; 
however, there are also some significant differences between them (in 
respiration rates, ATP levels and body size). These differences have 
prompted the question of how similar the C. elegans mitochondrial mutants 
really are to each other (Hekimi and Guarente 2003). Our microarray 
observations suggest that the overall nature of the response is similar, 
though the specific genes and the extent to which they are activated varies 
between mitochondrial mutants. Perhaps these differences are 
phenotypically significant; for example, clk-1 mutants may have normal 
respiration rates because they can compensate more fully than the other 
mutants to a primary respiratory-chain defect. On the other hand, there is a 
clear difference in the regulation of the clk-1 and isp-1 mutant phenotypes, 
since fstr-1/2 is necessary for the clk-1 mutant phenotypes but not for the 
isp-1 mutant phenotypes (Fig. 16). It will be interesting to learn how the isp-
1 and cyc-1 retrograde responses are regulated, and at what point these 
pathways converge to control the same downstream genes. 
 
 
 
Fig. 16 - C. elegans mitochondrial mutants activate similar retrograde 
responses in different ways. In this model clk-1 mutation decreases ubiquinone 
levels, which increases fstr-1 expression (possibly with the assistance of fstr-2, 
which is expressed constitutively). fstr-1/2 are then necessary for expression of 
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other genes that are part of the retrograde response, which in turn are likely to be 
responsible for the longevity and slowed phenotypes. clk-1, isp-1 and cyc-1(RNAi) 
mutants show similar retrograde responses, however, fstr-1/2 is necessary for the 
retrograde response of clk-1 but not isp-1 mutants. 
 
3.5 - Methods  
Strains 
The strains used in this study were: N2-Bristol (WT), fer-15(b26); fem-
1(hc17), clk-1(qm30) (Wong, Boutis et al. 1995), isp-1(qm150)(Feng, 
Bussiere et al. 2001), gei-7 (ok531), mev-1(kn1)(Ishii, Takahashi et al. 
1990), muEx491[pfstr-1::mCherry + podr-1::CFP], clk-1(qm30) ; muEx491, 
sEx11128[pgpd-2::GFP], isp-1(qm150); sEx11128[pgpd-2::GFP]. All strains 
used except for mev-1(kn1) were outcrossed to the laboratory’s N2 4 times. 
 
Microarray hybridizations 
We constructed microarrays using single-strand DNA oligos 
representing 20,374 unique C. elegans genes. These were purchased from 
Illumina® (DeRisi, Iyer et al. 1997). Populations were starvation-
synchronized as L1s overnight and collected at two different times: as L4s 
staged based on vulval morphology and as pre-fertile adults soon after the 
L4-to-young-adult molt, to guarantee maximum synchronicity between 
animals that grew to adulthood at different rates. Hybridizations were 
performed using standard techniques described in (Murphy et al. 2003). 
Total RNA was purified using TriZol™ reagent, mRNA was purified using 
Oligotex (Qiagen) and cDNA was labeled using Cy-dyes prior to 
hybridization. All chips described are direct comparisons between N2 and 
either clk-1(qm30), isp-1(qm150) or cyc-1(RNAi) in L4-staged or adult 
populations. We performed four independent biological repeats for each 
condition with the exception of clk-1(-) and isp-1(-) L4-staged populations, 
where we only collected data for 2 biological repeats. Dye-swaps and 
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technical repeats were averaged and analyzed as one biological repeat. 
Scanning was done using a GenePix 4000B scanner, and initial spot quality 
check was done using Genepix 6.0 software. During the analysis we used 2 
different sets of chips for each mutant: the “combined set” includes a 
combination of all L4 and adult chips, and the “adult-only set” only includes 
chips from populations collected as adults. 
 
Significance analysis 
The microarray data were analyzed twice over the several-year period 
spanned by these studies. The initial analysis, used to generate candidate 
genes that may be functional in the extended longevity of mitochondrial 
mutants, was performed on the combined set (L4 and adults) of 
microarrays. In this analysis, standard ratio-based normalization and default 
program settings for flagging missing or “bad” spots were used in the Acuity 
4.0 software package. Gene significance was calculated using the SAM 
software package. All of the lifespan analysis described herein was based 
on genes at the top of the list when the data were analyzed in this way. The 
second analysis, used to generate genes for use in the comparative GO 
analysis, was performed on the adult-only set of arrays. These data were 
renormalized using lowess as well as ratio based normalizations. On the 
assumption that genes within the same operon should in general have 
similar expression patterns, flagging parameters were adjusted to those that 
maximized the expression correlation of genes within the same operon on a 
“training” subset of the arrays. Genes not present in at least 3 of the arrays 
were not considered. These data were analyzed using the SAM software 
package and genes were considered significant below a FDR (false 
discovery rate) of 0.1. Data analyzed in this way were used for the GO 
analysis. 
 
Gene set overlap analysis 
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An algorithm, which we named the “p-q algorithm”, was designed and 
implemented in the Python programming language to determine the set of 
genes that are differentially regulated in all three combined (L4 and adult) 
microarray data sets. The algorithm takes as input a set of microarray 
hybridization data and estimates the q-value for each gene using the 
method described in (Storey 2002) and p-values estimated using Student’s 
t-test. It then iterates through each q-value and calculates the probability of 
seeing the observed number of genes that would be significant in all three 
data sets, should that q-value be used as the threshold for significance. The 
algorithm reports the set of genes that overlap between the three data sets 
at the q-value cut-off that achieved maximum overlap significance, as well 
as the probability of seeing such a degree of overlap by random chance. 
Probabilities are calculated using the hypergeometric distribution when 
possible, or the Poisson approximation when necessary. 
 
GO analysis 
GO categories were found using the BINGO software starting from a list 
of differentially expressed genes obtained from running SAM on the set of 
adult-only microarrays, with a significance cut-off of FDR <= 0.1 for each C. 
elegans mutant. Yeast GO categories were obtained by analyzing a dataset 
pooling differentially genes from two different publications (Epstein, Waddle 
et al. 2001; Traven, Wong et al. 2001).  
 
RNAi 
Bacterial feeding RNAi experiments were performed as described 
previously (Murphy et al. 2003). Clones were picked from Julie Ahringer 
RNAi library and were verified by sequencing. 
 
 
Survival measurements 
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Lifespan analysis was conducted as previously described (Dillin, Hsu et 
al. 2002). All assays were done at 25°C unless otherwise stated. The Stata 
8.0 software package (Stata Corporation) was used for statistical analysis 
and to calculate means and percentiles. In all cases p-values were 
calculated using the logrank (Mantel-Cox) method. 
 
Mitochondrial DNA quantification 
Mitochondrial DNA was quantified using Real Time-qPCR. We used two 
primer sets for mitochondria DNA graciously provided by Dana Miller:  
Mito1: Forward:GTTTATGCTGCTGTAGCGTG, 
Reverse:CTGTTAAAGCAAGTGGACGAG; 
Mito2: Forward:CTAGGTTATATTGCCACGGTG,  
Reverse:CAATAAACATCTCT-GCATCACC.  
The results were normalized to genomic DNA using a primer pairs 
specific for ama-1 and nhr-23:  
ama-1: Forward: TGGAACTCTGGAGTCACACC,  
Reverse: CATCCTCCTTCATTGAACGG;  
nhr-23 : Forward:CAGAAACACTGAAGAACGCG,  
Reverse:CGATCTGCAGTGAATAGCTC.  
Animals were grown and collected as described above for microarray 
studies and lysed in a standard buffer containing proteinase K for 1 hour at 
65°C. qPCR was performed using SYBR® GREEN PCR Master Mix 
(Applied Biosystems). Each comparison pools 5 biological repeats.  
 
Rates of growth and behavior 
Time to adulthood was measured as time (± 2 hours) at which 95% of 
animals reached adulthood. Measurements shown represent pooled data 
from five independent experiments, error bars represent SEM. Pumping 
rate was measured as the average number of pharyngeal pumps per 
minute (n = 10) over three independent trials. Thrashing rate was measured 
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as the average number of body thrashes in M9 buffer in one minute (n = 10) 
in three independent trials. All measurements were conducted on three day 
old adult animals. 
 
Quantitative RT-PCR 
Real-time RT-PCR was carried out using the 7300 Real Time PCR 
System (Applied Biosystems, Foster City, CA, USA). Primers and probes 
were designed specifically for each gene using Primer3 software. 
 
Construction of the Pfstr-1::mCherry promoter fusion  
To generate Pfstr-1::mCherry-expressing animals, a Pfstr-1::mCherry 
construct was made using the Invitrogen Gateway® Cloning technology, the 
promoter was amplified from genomic DNA using a primer set obtained 
from Mark Vidal’s online promoterome database (Forward: 
ggggacaactttgtataga aaagttgaggccagctttagataat; Reverse: 
ggggactgcttttttgtacaaacttgtcatctgaaatt tgaatgtgttagt). The construct obtained 
was sequenced and injected as described (Mello and Fire, 1995) at 10 ng/µl 
into N2 animals to generate a transgenic line (indicated by muEx491 
designation). The coinjection marker Podr-1::GFP was injected at 50 ng/µl.  
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Chapter IV 
Final Considerations on Mitochondria and 
Aging 
 
Aging research has made significant advances in the last 15 years with 
the discovery of many genes that regulate longevity, somewhat surprisingly 
so, considering what evolutionary theories had anticipated. Roughly, these 
genes can be grouped into three distinct pathways: Insulin/IGF-1 signaling 
and other DAF-16/FOXO-dependent pathways, dietary restriction and 
mitochondrial inhibition. The most recently identified and least understood 
of the three is the mitochondrial pathway. 
 Prior to the work presented here, little was known about how 
mitochondrial mutations affected longevity and no genetic regulators of this 
pathway had been identified. In addition, although there was some 
evidence supporting evolutionary conservation of the relationship between 
mitochondria and increased longevity, no mechanism had been identified 
that would explain said connection. The work presented in this thesis 
identifies retrograde regulation as a likely candidate for the conserved 
mechanism linking mitochondria to increased longevity. Long-lived yeast 
cells with impaired mitochondrial function have a well-documented 
retrograde response that is necessary for their increased longevity. The 
data presented here suggests that in C.elegans, the mitochondrial mutants’ 
increased longevity is a direct consequence of the activation of a retrograde 
response very similar to the one present in yeast. Several lines of evidence 
support this: Firstly, the expression profiles of these long-lived C. elegans 
mitochondrial mutants are highly similar to the ones observed in long-lived 
yeast cells. Secondly, knocking-down some of the genes up-regulated by 
this mitochondrial retrograde response (aqp-1, fstr-1/2 and cdr-2) in 
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mitochondrial mutants leads to a significant decrease in longevity, thus 
arguing that these genes are necessary and, very likely, partially 
responsible for the long-life phenotype of these animals. Thirdly, fstr1/2, a 
suppressor of clk-1 phenotypes, is necessary for at least several genes in 
the worm’s retrograde response to be induced, providing further evidence 
that the retrograde response has a likely role in longevity. These findings 
suggest an important and evolutionarily conserved role for retrograde 
regulation in longevity. Since retrograde regulation has been described in 
mammalian cells, it would be very interesting to test whether the long-lived 
mouse mitochondrial mutants Mclk-1+/- have similar expression profiles to 
the ones found in yeast and worm long-lived mitochondrial mutants. Also, 
comparing expression profiles of these long-lived mitochondrial mutants to 
the expression profiles of other long-lived mutants (IIS, DR) is likely to shed 
light on important common regulators of longevity. 
As for how mitochondrial impairment can actually lead to increased 
longevity, the gene expression profiling studies together with RNAi knock 
down data suggest a role for stress response and metabolic 
rearrangements (see section 3.4.3). 
cdr-2 is an important stress response protein and is necessary for isp-1 
mutants’ increased longevity, also gei-7, essential for the glyoxylate cycle, 
is necessary for cyc-1(RNAi) treated animals to live long. It is tempting to 
speculate that since the mitochondria are the main source of ROS, which 
are a likely cause of aging, localized increased expression in stress 
response genes may ameliorate this oxidative damage. It is also possible 
that the mitochondria act as a cellular stress sensor. In this case, by 
impairing mitochondrial function we are “tricking” cells into activating a 
robust stress response. This response, in turn, overshoots the added 
damage of the mutations and leads to an increase in longevity. It is 
interesting that several xenobiotic response genes are induced (see section 
3.3.1 and 3.3.6) in these mitochondrial mutants. It would be important to 
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determine what role these genes have in lifespan and whether these long-
lived mitochondrial mutants show increased resistance to xenobiotics. 
Consistent with this, a role for xenobiotic resistance in longevity has already 
been proposed regarding the insulin/IGF-1 pathway (McElwee, Schuster et 
al. 2004).  
An interesting hypothesis on how metabolism could be influencing 
longevity also takes into account cellular oxidative damage. Since the ETC 
and cellular respiration are important sources of ROS, then, activation of 
alternative metabolic pathways could lead to decreased oxidative damage. 
It is possible that the alternative metabolic pathways that are active in these 
long-lived mitochondrial mutants generate less ROS than mitochondrial 
respiration, and in that way, extend the animals’ longevity. It is important to 
note that these alternative pathways also generate significantly less energy 
than mitochondrial respiration, and for that reason are less likely to be 
active under normal circumstances. From this, we can speculate that 
animals are optimized for energy production, not longevity. As a follow-up to 
this study, it would be interesting to use standard biochemical assays to 
determine with certainty what metabolic pathways are active in these 
mutants. From there, it would be possible to supplement the media with 
certain intermediate metabolites to try to understand whether the 
hypothesis proposed in this thesis is correct, namely, whether glutamate is 
a central metabolite in the retrograde response (See section 3.4.1). 
Importantly, this work identified fstr-1/2, which is necessary for the 
increased longevity of clk-1 mutants. This is the first player in a potential 
pathway connecting mitochondria and longevity. It would be interesting to 
see if fstr-1/2 also has a role in other longevity pathways such as 
insulin/IGF-1 or dietary restriction. Such experiments could establish it as a 
more general mechanism regulating longevity in C. elegans.  
The “slowness” of these long-lived mitochondrial mutants has been 
suggested to be a passive consequence of decreased energy availability 
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caused by lowered mitochondrial function. The increase in longevity 
observed would have a similar explanation, where decrease in metabolic 
output would also passively lead to less ROS production. The fact that 
knockdown of a regulatory molecule, fstr-1/2, increases movement rates 
irrespective of energy availability suggests that these mitochondrial mutants 
actively “slow down” their behavioral rates. It is possible that this slowing 
down is an attempt to adjust the organisms’ energy expenditure to its 
energy production ability. Most importantly, however, this suggests the 
existence of a physiological mechanism responsible for adjusting rates-of-
living to energy expenditure.  
Based on this model, it is interesting to note that the important stage for 
the decision affecting longevity and behavioral rates is late in development 
(see chapter II), if mitochondrial impairment occurs only in adulthood no 
longevity benefit is observed. During development, animals make certain 
developmental choices depending on the environmental conditions such as 
temperature and energy availability. It is tempting to speculate that this 
regulation of rates-of-living in response to energy availability is one of these 
decisions, which also has implications on aging and longevity. Significantly, 
these findings also argue that events occurring early in development can 
influence longevity during the animal’s whole life. An interesting question 
with potential implications for therapeutic design is whether this lifespan 
extending retrograde pathway can also be activated in adults animals. 
A somewhat surprising observation was that fstr-1/2’s effect on 
longevity is specific to clk-1 mutants. As shown in section 3.3.8 fstr-1/2 is 
not needed for respiration deficient mitochondrial mutants to live long. This 
further reinforces the notion that although these long-lived C.elegans 
mitochondrial mutants share several similarities there are some significant 
differences (see section 1.4.3). Conversely, they do share similar 
transcription profiles. Based on this, a likely scenario is that they activate 
similar responses modulating longevity, but do so through different 
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mechanisms. In the future, it would be interesting to look for molecules 
regulating the longevity of these respiration deficient mitochondrial mutants.  
fstr-1 is expressed in neurons and in the intestine, however its effects 
are on the whole organism. Bearing this in mind, because the whole animal 
is affected by the clk-1 mutation, it is likely that FSTR-1 either is, or 
controls, a secreted signal that regulates the physiology of the entire 
animal. Alternatively, perhaps FSTR-2 acts in other tissues to influence 
lifespan. An attractive model (see section 3.4.4) proposes that decreases in 
ubiquinone levels signal an increase in fstr-1/2, which contributes to the 
activation of a retrograde response. This, in turn, leads to increased 
longevity. However, the mechanism of action of fstr-1/2 still requires much 
elucidation, and this is essential for the understanding of this pathway. 
Further biochemical characterization of fstr-1/2 would likely shed light on 
the mechanisms by which it is helping to promote longevity, and potentially 
allow the identification of other players in this pathway. 
Overall, this work provides very significant insight into a longevity 
pathway that was almost completely unexplored. It has addressed some of 
the broader questions regarding mitochondria and longevity in C. elegans. 
In doing so, however, it inevitably generated more questions than answers. 
These findings represent a solid stepping-stone on the way to 
understanding the complex relationship between mitochondria and 
longevity. 
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